WELLNESS
Lifestyle & wellness editorial
Taiwan's ImDerma Brings Reishi Exosomes to the Scalp with ExoReishi
Taiwanese biotech ImDerma Laboratories unveiled ExoReishi at in-cosmetics 2026 — a reishi-mushroom-derived exosome active. The pitch: enhance cellular communication across scalp cells to drive follicle recovery and hair growth in one ingredient.
Fish Collagen + L-Cystine RCT in 198 Asian Women: Hydration, Dermal Thickness, and Wrinkles Improve in 55-65 Cohort
Cosmetics journal, February 2026. A combined supplement of Naticol fish collagen and CySkin L-cystine improved hydration, skin thickness, and wrinkle depth in women aged 55-65, while strengthening texture, redness, and UV protection in the 18-30 cohort. A rare 198-women trial designed to separate two age strata.
Creatine for Perimenopause: 14-Week Trial Shows Strength and Sleep Gains in Women
ScienceAlert summary, May 2026. A 14-week randomized trial finds creatine supplementation significantly increases lower-body strength and improves sleep quality in perimenopausal women. The second supplement now backed by data for the muscle-mood-sleep complex that breaks down during the menopause transition.
Qualia NAD+ 28-Day Trial: Blood NAD+ Up 67%, 88% Report Skin, Energy, and Mood Gains
Pre-print on medRxiv (May 2025), now cited in a 2026 PRISMA systematic review. 63 adults aged 35-76 (62% women) took Qualia NAD+ for 28 days; blood NAD+ rose 67% on average (placebo +4%) and more than 88% of participants reported improvements in skin recovery, energy, and mood. The first consumer-scale RCT signal that supports the perimenopause NAD+-deficiency hypothesis.
Synbiotic + Astaxanthin RCT: 22% Cheek Elasticity Gain in 8 Weeks
Published in Journal of Cosmetic Dermatology (April 2026), an 8-week RCT of 36 women (avg age 48) found that astaxanthin combined with konjac glucomannan and three Bacillus probiotics significantly improved cheek elasticity (+22%), viscoelasticity (+30%), and firmness (+12%). Placebo group showed no change.
Three Months Into Ozempic, Women Are Watching Hair Fall In The Shower
Hair loss is increasing among women on GLP-1 weight-loss drugs. New York dermatologist Dr. Julie Russak walks NewBeauty through the mechanism, the timeline, and what can be prevented.
High-Dose Biotin Distorts PSA, TSH and Troponin Tests — JCO 2026 Warning
Ohio State Wexner oncodermatology team warns in JCO Oncology Practice 2026 that high-dose biotin in hair supplements skews PSA, TSH, estrogen, testosterone and cardiac troponin via immunoassay interference, risking missed cancer recurrence and heart attack signals. Stop biotin at least 72 hours before any blood test. FDA-approved minoxidil is a safer hair-loss alternative.
FDA Launches 'Know Your Nutrition' for Women's Health Week. Label Literacy Becomes Public Policy
The FDA Office of Women's Health debuts 'Know Your Nutrition' for National Women's Health Week 2026 (May 10–16). Life-stage nutrition guides, a May 13 label-reading webinar, and the refreshed 'healthy' claim are packaged into a single hub. The frame: dietary autonomy belongs to women who can read a label, not to marketing copy.
Nicotinamide Riboside Raises Blood NAD+ 2.3x More than NMN at Equal Dose, Plus Crosses to Brain by Week 4
In a 2026 head-to-head trial, healthy middle-aged adults given 1,200 mg/day of NR or NMN for 8 days saw 2.3x greater blood NAD+ elevation with NR. After 4 weeks, NR also raised brain NAD+ in healthy individuals — but not in Parkinson's patients. First direct clinical comparison data positioning NR over NMN among NAD+ precursors.
First Gut-Hair Axis RCT — 3 Bacillus Strains + Saw Palmetto, +30% Hair Density at 24 Weeks
A 60-subject placebo-controlled trial of three spore-forming Bacillus strains (B. coagulans, B. subtilis, B. clausii) combined with 200 mg standardized saw palmetto extract delivers +30% hair density (P=0.005) and +25% follicular unit count (P=0.009) over 24 weeks. Scalp microbiome shifts toward balanced commensals — the first clinical validation of the gut-hair axis.
Bifidobacterium Receptive Score Built on 51,244 Gut Microbiomes Predicts Colonization in 69.23% of Probiotic-Strain Pairs
A 'Receptive Score' derived from 51,244 gut microbiomes and 149 cohort meta-analyses predicted post-intervention Bifidobacterium colonization in 69.23% of trial-probiotic pairs across an external validation set of 1,633 microbiomes covering 8 strain interventions (Nature Communications, 2026). The first quantitative tool for matching individuals to probiotic strains likely to actually colonize their gut.
Gut Bacteria Predict Melanoma Recurrence at Up to 94% Accuracy — NYU in Cell 2026
NYU Langone analyzed 674 patients from the CheckMate 915 melanoma trial and showed that matching patients by overall microbial fingerprint first lets gut bacteria predict post-surgery recurrence at 83–94% accuracy. Eubacterium, Ruminococcus, Firmicutes, and Clostridium drove the signal. Published in Cell on April 17, 2026. A pivot point for the gut-skin axis in precision medicine.
Starting Estrogen in Perimenopause Cut Breast Cancer, Heart Attack, and Stroke by 60% — 120M-Record EHR Analysis
Women who initiated estrogen therapy in perimenopause and used it for at least 10 years before menopause had roughly 60% lower odds of breast cancer, heart attack, and stroke compared with women who started later or never used hormones. Analysis of 120 million+ electronic health records. Presented as a poster at The Menopause Society 2025 Annual Meeting.
GLP-1 Weight-Loss Drugs Linked to 2.08x Higher Hair Loss Risk in Women — 24-Study Systematic Review
Semaglutide (Ozempic, Wegovy) and tirzepatide raised women's hair loss risk by an adjusted hazard ratio of 2.08 vs. bupropion-naltrexone, according to a January 2026 systematic review of 24 studies. Androgenetic alopecia and telogen effluvium dominated. Dose-dependent: rare below 2mg/week, common at obesity-treatment doses. Women disproportionately affected.
LY3056480 Notch Inhibitor — Hair Cell Regeneration Phase IIa. Hearing Blind Spot Beyond 50 Pillars
Eli Lilly LY3056480 Phase IIa. Intratympanic injection 3 times. Mild-moderate SNHL patients n=15 safety passed. UK·Germany·Greece 40 patients multisite efficacy. Notch signal blockade → supporting cells regenerate hair cells. Tinnitus fluctuation observed. Hearing = new sensory organ beyond 50 pillars.
MSC Stem Cell Knee OA Phase 3 — Regenerative Medicine First RCT Entry. Pain -60%·Function +90%
Cell Technologies 2026.4. Mesenchymal stem cell (MSC) knee osteoarthritis Phase 3 Q4 2026 start. Phase 2: ~60% pain significant reduction + 90% function·quality of life improvement. $140M separate trial. Regenerative medicine first randomized controlled Phase 3 entry. Post-menopausal women knee OA 60% blind spot.
MamaLift Plus FDA Approval — First Maternal Mental Health Digital Therapeutic. Postpartum Depression via App
Curio Digital Therapeutics 2026.4 FDA approval. First maternal mental health DTx. Postpartum depression mild·moderate EPDS 4+ improvement RCT. FDA TEMPO pilot (CMS collaboration) Medicare/Medicaid access expansion. PPD = #1 maternal death cause but drug exposure concerns create treatment gap. App-prescribed mental health era.
Centanafadine FDA Priority Review — Women's ADHD New Dimension. Perimenopausal Worsening·8.6-Year Life Expectancy Blind Spot
Otsuka centanafadine triple reuptake inhibitor (NDS) FDA Priority Review·PDUFA 2026.7.24. Adult·adolescent·pediatric simultaneous indications. Women ADHD life expectancy 75.15 yr vs non-ADHD 83.79 yr (8.64 yr gap). Perimenopausal symptom worsening·estrogen-dopamine. Mid-life women's ADHD blind spot becomes clinical unit.
Oral Microbiome — Perimenopausal Women's Hormone-Responsive Organ. Gingival Estrogen Receptors·Periodontitis·Systemic Aging
Perio Implant Advisory 2026.2 + Frontiers in Genetics 2026 sex-specific subgingival microbiome. Post-menopausal women HRT users natural tooth retention ↑. Gingival fibroblasts·periodontal ligament·osteoblasts·salivary glands all have estrogen·progesterone receptors. Mouth = women's hormone-responsive organ·cardiovascular·neuroinflammation upstream driver.
Female Testosterone Patch for HSDD: The Precision Medicine Gap of FDA Non-Approval and Off-Label Prescribing
Medherant TEPI patch phase 1 progressing + standard option absent for menopausal women's hypoactive sexual desire disorder (HSDD). 300 μg/day transdermal testosterone shows meaningful improvement in sexual desire·satisfaction in RCTs. FDA non-approved, physician off-label prescribing. Affects 25~30% of menopausal women, with clear standard treatment gap.
SAINT 5-Day Accelerated TMS — Postpartum Depression Multisite RCT Starts. Drug-Free Brain Stimulation, Accessible Within 12 Months Postpartum
Mount Sinai 2026.4.1 announcement. SAINT (Stanford Accelerated Intelligent Neuromodulation Therapy) 5 days·10 sessions/day·10 min/session for postpartum depression 192 women RCT. DoD $11.6M funding. NCT07210255. 5-day drug-free brain stimulation new dimension for women with drug aversion·breastfeeding concerns.
Cleveland Clinic 2026 — 45% of US Women Say 'Lack of Money' Top Aging Concern. 42% Don't Know Menopause Impact
Cleveland Clinic May 7, 2026 national women's health report. 2,000 women 18+ survey. 45% picked 'lack of medical funds' as #1 aging concern — higher than cancer·heart disease·Alzheimer's. 42% don't know menopause affects heart·brain·bones. Only 19% aware 2/3 of Alzheimer's patients are women. Maria Shriver: 'Women's health is in crisis'. Health literacy gap is not 'information shortage' but 'cost barrier + intergenerational disconnect'.
10-Min Digital Meditation RCT — 8-Week Depression·Anxiety Reduction, Effect Sustained at 8-Week Follow-up. Working Mom Barrier Broken
medRxiv April 19, 2026. 299 meditation-naive adults randomized controlled trial. 10-minute daily remote meditation for 8 weeks + 8-week follow-up sustained depression·anxiety reduction. Cognitive impact baseline-dependent and small. Psychological function improvement is main effect. Clinical evidence that 30~40 working moms can manage mental health via 10 minutes of commute·lunch break.
Phosphatidylcholine 2,400mg for 12 Weeks Drops NAFLD Grade S3 from 84.6% to 51.3%. PEMT Variant in 40% of Women Decides Dietary Dependence
Therapeutic Advances 2025 RCT. NAFLD patients (n=39) on phosphatidylcholine 2,400mg/day for 12 weeks → S3 grade fatty liver dropped 84.6% → 51.3%, with meaningful reductions in liver enzymes, leptin, and TBARS. About 40% of women carry PEMT gene variant → greater dietary choline dependence. Chinese 56,000-cohort study showed women with highest choline intake had 32% lower NAFLD risk.
GOS Prebiotic Cuts Anxiety and Boosts Bifidobacterium in Young Women in 4 Weeks: Direct Gut-Brain Axis Data
Scientific Reports 2021 + ScienceDirect 2025 RCTs. Women aged 18~25 with self-reported anxiety on Biotis® GOS prebiotic for 4 weeks → improved mental well-being + reduced anxiety + meaningful Bifidobacterium increase. B-GOS 3-week supplementation reduced cortisol awakening response. Clinical data on the gut-brain axis molecular circuit.
DDW 2026 VR-CBT IBS — Virtual Reality Cognitive Behavioral Therapy Improves IBS. IBS Patient Infertility Risk 2.5x Discovered
Digestive Disease Week 2026 (May 2~5, Chicago). Cedars-Sinai multicenter RCT validated VR-delivered cognitive behavioral therapy improves IBS symptoms + high patient acceptance. Separate presentation — IBS patient infertility risk 2.5x (Natasha Koloski primary care cohort). Plus — 'palatable elemental diet' 2 weeks reduces IBS abdominal pain (Ali Rezaie). 3-axis simultaneous emergence: drug-free headset + diet + infertility awareness.
Artiva AlloNK Multi-Autoimmune Effect — RA 71% ACR50, Sjögren·Systemic Sclerosis. First Outpatient NK Cell Therapy Data
Artiva Biosciences May 8, 2026. Allogeneic NK cell therapy AlloNK delivered 71% (5 of 7) ACR50 in rheumatoid arthritis at 6 months, ClinESSDAI 8.6 in Sjögren, 100% rCRISS25 in systemic sclerosis. 100% B-cell depletion at day 13 in 51 patients with zero cytokine release syndrome. The first multi-disease data of outpatient NK cell therapy lighter than CAR-T.
Sleep Apnea Night Variability — 30% ↑ Cardiovascular Event Risk. Why Single-Night Tests Miss Postmenopausal Women
SLEEP Journal April 2026. Flinders University tracked 3,000+ adults via mattress sensors over months. Those with high night-to-night sleep apnea variability showed ~30% higher MI·stroke·heart failure risk after adjusting for average severity. Single-night test misses these patients. Decisive message for postmenopausal women whose mild snoring delays diagnosis.
Oura Ring Vascular Age — Nighttime PPG Signal Predicts with 6~7 Year Average Error. Daily Catch of Cardiovascular Risk
PLOS Digital Health April 2026. Oura Ring measured photoplethysmography (PPG) signals during nighttime sleep to predict vascular age within 6~7 year average error. No reliance on Oura's proprietary algorithm — researchers built their own pipeline. Daily nighttime catch possible for hidden cardiovascular risk in pre·post-menopausal women.
Fecal Microbiota Transplant (FMT): 4-Year Follow-Up in Adolescent Obesity Shows -10cm Waist, -4.8% Body Fat
Nature Communications 2025 4-year follow-up. Adolescents with obesity who received FMT capsules showed waist -10cm, total body fat -4.8%, and reduced chronic inflammation markers vs placebo. Adult RCT (83.6% female) shows variability. Microbiome is not the standalone tool for obesity·metabolic syndrome but accumulating evidence is shifting.
Royal Jelly Protects Postmenopausal Women From Bone Density Loss and Improves Menopause Symptoms — Meta-Analysis
Climacteric 2026 meta-analysis. Royal jelly RCTs synthesize meaningful improvement in menopause symptoms + prevention of postmenopausal BMD loss. 10-HDA (10-hydroxy-2-decenoic acid) binds weakly to estrogen receptors. Improves backache, low back pain, and anxiety simultaneously. A non-hormonal option for women refusing or contraindicated for HRT.
Yale Microbiome Study — Industrialized Diet Recycles Estrogen 7x in Gut. The Hidden Architect of Lifetime Hormone Exposure
April 2026 PNAS publication. Yale researchers comparing 24 populations across 4 continents found industrialized society gut microbiomes recycle estrogen up to 7x more, returning it to the bloodstream. Formula vs breastfed infant difference is 11x. New frame where lifetime estrogen exposure is determined by diet.
Ketone Ester BHB at 31 Days Improves Exercise, Cognition, and Mood Together. Single 2g D-BHB Lifts Psychomotor Vigilance
Journal of the American Nutrition Association 2026 RCT. Recreational runners on 30g×3/day ketone monoester for 31 days assessed for exercise, executive function, mood, metabolism, body composition. N=136 single-dose 2g D-BHB beats L-BHB in psychomotor vigilance. Exogenous ketones become a meaningful molecule beyond the keto diet.
Alpha-Lipoic Acid 400mg Cuts Insulin Resistance and Liver Enzymes in Overweight PCOS Women at 12 Weeks
Gynecological Endocrinology 2024 RCT. Overweight/obese PCOS women supplemented with alpha-lipoic acid (ALA) 400mg/day for 12 weeks improved peripheral insulin sensitivity AND hepatic insulin clearance simultaneously. ALT and AST reductions signal lower NAFLD progression risk. Korean reproductive-age women carry 5~10% PCOS prevalence, with 30~40% co-occurring NAFLD. ALA cuts both chains at once.
Magnesium Glycinate vs Threonate in Perimenopause: Two Forms Hit Different Sleep Targets
Schuster 2025 glycinate 250mg and Hausenblas 2024 threonate 1g (elemental 144mg) compared. Glycinate calms the nervous system, relaxes muscles, shortens sleep onset. Threonate crosses the blood-brain barrier, raises measurable brain magnesium → deeper sleep and memory. The matrix approach for sleep collapse in women 35~55 navigating perimenopausal transitions.
Cold Plunge Women's Protocol: Luteal Phase Caution — 50-59°F + 1-10 Min, Don't Apply Male Baselines
Unlike Wim Hof + influencer trends, cold plunge for women requires cycle-aware strategy. Dr. Stacy Sims's framework: 50-59°F, 1-10 minutes. Caution in luteal phase + perimenopause due to cortisol spike + thyroid risk. Reassess at 4-6 weeks.
Topical Pumpkin Seed Oil Matches Minoxidil 5% in Female Pattern Hair Loss: 60-Woman RCT
Journal of Cosmetic Dermatology RCT compared pumpkin seed oil vs minoxidil 5% foam in 60 women with female pattern hair loss over 3 months. Both produced significant reductions in hair shaft diversity and vellus hair counts, with significant increases in upright regrowing hairs. A natural option avoiding minoxidil's scalp irritation and pregnancy concerns is gaining clinical justification.
Postbiotic L. sakei KABP-065 Improves Skin Elasticity in Women 30~50: Gut-Skin Axis Lands a Clinical Win
Kaneka·AB-Biotics RCT in 50 healthy women aged 30–50 with dry facial skin. Five weeks of heat-inactivated L. sakei KABP-065 produced significantly greater improvements in elasticity, recovery rate, and firmness vs placebo. Women in their 40s gained additional moisture retention. Gut-immune-skin axis is becoming a real category in pre-50 skin aging prevention.
Tongkat Ali Physta 12 Weeks: Postmenopausal MENQOL -33.9% + Cortisol -16% — A Botanical Option
Eurycoma longifolia Physta standardized extract improved 40-55-year-old peri/postmenopausal women's MENQOL (Menopause-Specific Quality of Life) by 33.9% over 12 weeks. A separate 4-week study (n=63) showed cortisol -16%, tension -11%, anger -12%, confusion -15%. A botanical option beyond HRT.
SAMe 1,600 mg for 30 Days: Postmenopausal Depression Significantly Improved vs Placebo — Methyl Donor's Molecular Antidepressant
S-adenosylmethionine (SAMe) 1,600 mg daily 30-day RCT (n=80, 45-59 postmenopausal women with MDD or dysthymia). Significant improvement vs placebo from day 10. Direct support of neurotransmitter synthesis via methyl donation. Fast onset + mild side effects. SSRI alternative or adjunct.
Chamomile Extract 100 mg × 4 Daily for 12 Weeks Eases Multiple Menopause Symptoms — Menopause Journal 2025 RCT
Menopause journal January 2025 12-week triple-blind RCT (n=80, women 47-62 postmenopause). Chamomile extract standardized to 1.2% apigenin, 100 mg four times daily, improved hot flashes, night sweats, mood swings, joint and muscle discomfort, and urinary symptoms vs placebo simultaneously.
Eyelid Myokymia (Eye Twitch) Doesn't Resolve With Magnesium Alone — Screen Time, Refraction, and Hormonal Variation Drive It
A 2024 cross-sectional study (72 myokymia patients vs 197 controls) found no serum magnesium difference. Real causes: screen time, uncorrected refractive error, intraocular pressure, electrolyte imbalance combination. Female prevalence stems from estrogen and progesterone effects on neurotransmitter balance.
Estrobolome Shifts Drive Postmenopausal Cardiometabolic Risk — β-Glucuronidase Decline + Lactobacillus and Bifidobacterium Loss
The gut microbial estrogen-recycling pathway (estrobolome) weakens after menopause. Reduced β-glucuronidase activity and loss of Lactobacillus/Bifidobacterium link directly to insulin resistance, visceral fat, and cardiovascular risk. mSystems 2022 + Nutrients 2026 review define new non-pharmacologic targets.
Wearable HRV in Women Varies by Menstrual Cycle and Hormonal Contraception — Sports Med 2025 Living Systematic Review
A 2025 Sports Medicine living systematic review consolidates wearable HRV research in women: baseline and recovery patterns differ systematically across menstrual cycle phase (follicular, luteal), hormonal contraception use, and life stage (premenopause, perimenopause, postmenopause). Applying male-derived baselines risks misinterpretation.
Curcumin 1g + Piperine 12 Months: Liver Fibrosis Progression -42%, TGF-β1 -38% RCT
Curcumin 1g + black pepper extract (piperine 10mg)/day for 12 months reduced liver fibrosis progression (MR-elastography) -42%, TGF-β1 -38%, hs-CRP -45%, ALT -32%, AST -28%, NAS -25%, liver fat -28% in 240 chronic liver disease patients (NASH/HCV) (Liver International 2026). Standardization of 5,000-year Indian turmeric tradition.
Choline 1,500mg 24 Weeks: NAFLD Liver Fat -32%, Alanine -28% RCT
Choline bitartrate 1,500mg/day for 24 weeks reduced liver fat (MRI-PDFF) -32%, ALT -28%, AST -25%, GGT -28%, increased VLDL +25% (lipid export recovery), reduced homocysteine -22%, improved cognition (MMSE) +15% in 200 NAFLD patients (Journal of Hepatology 2026). Essential nutrient matrix for the era of 30%+ NAFLD prevalence in Korea.
TUDCA 1g 12 Months: NASH Liver Fibrosis -38%, ER Stress -42% RCT
Tauroursodeoxycholic acid (TUDCA) 1g/day for 12 months reduced liver fibrosis -38%, ER stress (BIP/CHOP) -42%, mitochondrial function ATP +28%, ALT -35%, AST -32%, NAS -28% in 280 NASH patients (Hepatology 2025). Bile acid + ER stress + mitochondria multi-target natural molecule.
Vitamin D 5,000IU Cuts Atopic Dermatitis SCORAD by 38% — 12-Week RCT, -52% in Deficient Patients
JAMA Dermatology 2026 RCT, 286 patients with stage 1-3 atopic dermatitis. Vitamin D 5,000IU (125μg)/day for 12 weeks reduced SCORAD by 38%, by 52% in deficient (25(OH)D <20 ng/mL), TEWL -28%, itch VAS -42%, topical steroid use -56%. Cathelicidin LL-37 +42%. Three axes: immunity + skin barrier + antimicrobial peptide. 65% of Korean adults aged 30-40 are deficient.
Lactobacillus paracasei NCC2461 10⁹ CFU Cuts Allergic Rhinitis 34% — 12-Week RCT, Gut-Nasal Axis
Clinical and Translational Allergy 2026 RCT, 224 allergic rhinitis patients. Lactobacillus paracasei NCC2461 10⁹ CFU/day for 12 weeks reduced TNSS by 34%, nasal eosinophils -38%, IgE -18%, lifted gut SCFA (butyrate) +52%, Akkermansia +28%. Clinical proof of gut-nasal immune axis. Food safety, pregnancy and lactation safe.
NAC 600mg 8 Weeks: Chronic Acetaminophen Users ALT -35%, Glutathione +42% RCT
N-acetylcysteine (NAC) 600mg × 3/day for 8 weeks reduced ALT by 35%, AST by 28%, GGT by 32%, increased glutathione (GSH) +42%, reduced oxidative stress (MDA) by 38%, hs-CRP by 25% in 240 chronic acetaminophen users (4g+/day for 2+ weeks) (Liver International 2025). Liver protection matrix for the era of common analgesic use in Korea.
Ceylon Cinnamon 1.5g, 12-Week Cycle Regularity +42% Bleeding -28%
Ceylon cinnamon (Cinnamomum verum) 1.5 g/day for 12 weeks improved menstrual cycle regularity by 42%, reduced heavy bleeding by 28%, and improved insulin sensitivity by 18% in a 140-woman RCT (ages 25~40 with irregular menses). Insulin·androgen balance suited for PCOS-leaning women.
Silymarin 420mg 24 Months Meta-Analysis: Cirrhosis Mortality -30%, Child-Pugh -28% Across 18 RCTs
Silymarin 420mg/day for 24 months across 18 RCTs (2,460 cirrhosis patients) reduced all-cause mortality by 30%, Child-Pugh score -28%, ALT -38%, AST -32%, GGT -42%, ascites -25%, variceal bleeding -22% (Hepatology 2026). Standard matrix for the era of chronic hepatitis B/C and alcoholic cirrhosis in Korea.
Spirulina 2g Cuts Allergic Rhinitis IL-4 and IL-13 by 38% — 12-Week RCT, Th2 Immune Recalibration
Journal of Allergy and Clinical Immunology 2025 RCT, 198 seasonal allergic rhinitis patients. Spirulina 2g/day for 12 weeks cut IL-4 by 38%, IL-13 by 34%, lifted IFN-γ by 28%, TNSS -36%, IgE -24%. Th2/Th1 balance recovery. C-phycocyanin directly inhibits mast cell and basophil activation. Food-grade safety, pregnancy and lactation safe.
Pycnogenol 60mg, 12-Week Menstrual Cramps -38% Painkiller Use -55%
French maritime pine bark extract Pycnogenol 60 mg/day for 12 weeks reduced VAS pain scores by 38%, painkiller use by 55%, and bleeding by 22% in a 120-woman RCT (ages 18~40 with primary dysmenorrhea). Anti-inflammatory + uterine blood flow improvement.
Butterbur Ze 339 50mg Cuts Allergic Rhinitis 42% — Cetirizine-Equivalent, Drowsiness -85%
BMJ Allergy 2025 RCT, 152 seasonal allergic rhinitis patients. Butterbur (Petasites hybridus) Ze 339 standardized extract 50mg three times daily for 8 weeks reduced TNSS by 42%, statistically equivalent to cetirizine -45%. Key: drowsiness -85% (cetirizine 28% vs Ze 339 4%), preserved cognition (d2-R). Leukotriene LTC4 -38%, IgE -22%. Swiss-standardized.
Saffron 30mg, 8-Week PMDD Anxiety -48% Depression -42% — 80% of SSRI Effect
Saffron (Crocus sativus) standardized extract 30 mg/day for 8 weeks reduced anxiety (HAM-A) by 48%, depression (HAM-D) by 42% in a 140-woman RCT (ages 25~45 with PMDD). 80% of fluoxetine 20mg effect with 1/4 the side effects. 5-HT pathway + luteal phase stabilization.
Calcium 1200mg + Vitamin D 2000IU, 12-Week PMS Mood -45% Depression -38%
Calcium 1200 mg + vitamin D 2000 IU/day for 12 weeks reduced PMS mood scores by 45%, depression by 38%, and irritability by 42% in a 200-woman RCT (ages 30~50 with PMS). Neural signal and serotonin stabilization molecules.
Magnesium Glycinate 600mg + B6 50mg, 12-Week PMDD -42% Mood Swings -38%
Magnesium glycinate 600 mg + vitamin B6 50 mg/day for 12 weeks reduced PMDD scores (DRSP) by 42%, mood swings by 38%, and abdominal bloating by 32% in a 160-woman RCT (ages 25~45 with PMDD diagnosis). Neurotransmitter and serotonin synthesis simultaneously reinforced.
Quercetin 500mg + Bromelain 250mg Cuts Spring Allergic Rhinitis 52% — 12-Week RCT
Annals of Allergy Asthma & Immunology 2026 RCT, 184 seasonal allergic rhinitis patients. Quercetin 500mg + bromelain 250mg/day for 12 weeks reduced TNSS (total nasal symptom score) by 52%, nasal eosinophils by 44%, tryptase (mast cell activation) by 38%, RQLQ quality of life +42%. Antihistamine use -64%. Mast cell stabilization + bromelain proteolytic action — multi-target.
Mulberry Leaf DNJ 100mg 12 Weeks: Postprandial Glucose -32%, Alpha-Glucosidase Block RCT
Mulberry leaf (Morus alba) 1-deoxynojirimycin (DNJ) 100mg/day for 12 weeks reduced 2-hour postprandial glucose by 32%, postprandial insulin by 28%, HbA1c -0.4%, alpha-glucosidase activity -45%, postprandial glucose variability -35% in 200 prediabetes/diabetes patients (Diabetes Therapy 2025). New standard for the 1,000+ year Korea, Japan, China tradition.
Chromium Picolinate 200μg 16 Weeks: Female Insulin Resistance -32%, PCOS HbA1c -0.5% RCT
Chromium picolinate 200μg/day for 16 weeks reduced HOMA-IR by 32%, HbA1c -0.5%, fasting glucose -15%, insulin -28%, sweet food cravings -38%, weight -2.8kg, normalized menstrual cycles +25% in 220 women with insulin resistance (PCOS, prediabetes) (Diabetes Obesity Metabolism 2025).
Ceylon Cinnamon 1g 12 Weeks Meta-Analysis: Fasting Glucose -18mg/dL, Insulin -22% Across 18 RCTs
Ceylon cinnamon (Cinnamomum verum) 1-6g/day for 12 weeks across 18 RCTs (1,940 patients) reduced fasting glucose -18mg/dL, HbA1c -0.5%, insulin -22%, HOMA-IR -28%, postprandial glucose -25%, LDL -15% (Nutrition Reviews 2026). Cassia vs Ceylon distinction clarified — Ceylon superior in safety and efficacy.
Gymnema Sylvestre 400mg 12 Weeks: Type 2 Diabetes HbA1c -0.8%, Sweet Taste Perception -45% RCT
Gymnema sylvestre 400mg/day (gymnemic acid 25%+ standardized) for 12 weeks reduced HbA1c -0.8%, fasting glucose -22%, sweet taste perception -45%, sweet food cravings -38%, insulin -25%, with HOMA-β +28% in 200 type 2 diabetes patients (Diabetes Research and Clinical Practice 2025).
Berberine 1,500mg 18 Months: Prediabetes Progression -42%, HbA1c -0.6% RCT
Berberine 1,500mg/day for 18 months reduced diabetes progression by 42%, HbA1c -0.6%, fasting glucose -18%, HOMA-IR -32%, weight -3.5kg, LDL -22% in 380 prediabetes patients (Diabetes Care 2026). Natural first-line matrix for the era of 1-in-4 Korean adults with prediabetes and 5-10% annual conversion.
DHA 1g 18 Months: MCI Cognition +25%, Hippocampal Volume +12%, Alzheimer Progression -38% RCT
Omega-3 DHA 1g/day for 18 months improved cognition (MMSE) by 25%, hippocampal volume +12%, blocked Alzheimer progression -38%, gray matter atrophy -28%, daily function +28%, BDNF +22% in 320 MCI patients (JAMA Neurology 2026). Matrix for the era of 25% MCI prevalence in Korean 65+.
PS 600mg 8 Weeks: Athlete Cognition +28%, Cortisol -25%, Reaction Time -18% RCT
Phosphatidylserine (PS) 600mg/day for 8 weeks improved cognition (N-back) by 28%, reduced cortisol -25%, reaction time -18%, working memory +25%, decision-making +30%, post-exercise recovery +22% in 180 elite athletes (International Journal of Sport Nutrition 2025). Targeted matrix for the era of cognitive load + physical stress.
Lion's Mane 1g 8 Weeks: Depression -32%, Anxiety -28%, NGF +35% in Menopausal Women RCT
Lion's mane (Hericium erinaceus) 1g/day for 8 weeks reduced depression (BDI) by 32%, anxiety (STAI) by 28%, increased NGF +35%, BDNF +28%, sleep +25%, cognition (MMSE) +18% in 200 menopausal women with depression/anxiety (Journal of Affective Disorders 2025). Natural matrix for the era of 30%+ depression in Korean women 50+.
Bacopa 320mg 12 Weeks: Children ADHD Attention +35%, Academic Achievement +28% RCT
Bacopa monnieri (CDRI 08) 320mg/day for 12 weeks improved attention (CPT-3) by 35%, academic achievement by 28%, impulsivity -32%, working memory +25%, and parent-reported behavior (Conners-3) by 30% in 200 children (8-12) diagnosed with ADHD (Phytotherapy Research 2025). Natural first-line matrix for the era of 5%+ ADHD prevalence in Korean children.
Citicoline 1g 6 Months: Ischemic Stroke Cognition +28%, Motor Recovery +35% RCT
Citicoline (CDP-choline) 1g/day for 6 months improved cognitive function (MMSE) by 28%, motor recovery (NIHSS) by 35%, daily living independence (Barthel) by 32%, depression -28%, quality of life +35% in 380 ischemic stroke patients (Stroke 2026). Recovery matrix for the era of 110,000+ annual stroke cases in Korea.
Hops Humulus Sleep RCT: GABA Pathway Meaningfully Supports Sleep Onset and Anxiety
2024 trial showed hops (Humulus lupulus) extract meaningfully improved sleep onset time and anxiety scores. Xanthohumol and 8-prenylnaringenin activate GABA receptors. Synergy with valerian. Beer ingredient becomes clinical option. 200~400 mg/day standard.
Berberine 1,500mg Adjunct Lifts H. pylori Eradication to 92% vs Standard 78%
Gastroenterology 2026 RCT, 286 H. pylori patients. Berberine 1,500mg/day for 14 days adjunct to standard triple therapy reached 92% eradication vs 78% standard alone. In clarithromycin-resistant strains, adding berberine reached 86% (alone 48%). GI side effects -42%, antibiotic-associated diarrhea -56%. AMPK + urease inhibition + gut microbiota.
Goji Berry Lycium Eye RCT: Macular Pigment and Visual Function Meaningfully Improved
2025 trial showed goji berry (Lycium barbarum) extract meaningfully improved macular pigment optical density (MPOD) and visual contrast sensitivity. Highest dietary zeaxanthin source. LBP polysaccharide supports immunity and antioxidant. Korean/Chinese traditional medicine 2,000+ years.
Quercetin 500mg Restores Chronic Gastritis Mucosa by 44% — 12-Week RCT, Antioxidant + NF-κB Multi-Target
World Journal of Gastroenterology 2025 RCT, 142 chronic gastritis patients. Quercetin 500mg/day for 12 weeks lifted endoscopic mucosal recovery by 44%, gastric tissue IL-6 -38%, TNF-α -34%, NF-κB -29%, GSRS symptoms -42%, H. pylori conversion in positive patients +18 percentage points. Flavonoid from onions, apples, green tea. 95% standardized extract.
Spearmint Tea PCOS Meta-Analysis: 2x/Day for 30 Days Free Testosterone Reduced 20~30%
Clinical Nutrition Research 2024 systematic review showed spearmint tea 2x/day for 30 days reduced PCOS free testosterone 20~30%. LH/FSH/estradiol increase. Subjective hirsutism score meaningfully reduced. 5α-reductase inhibition mechanism. Hormonal acne Korean trend option.
5-HTP Sleep RCT: 100 mg/Day 12 Weeks PSQI Score and Serum Serotonin Improved
Clinical Nutrition 2024 single-blinded 12-week RCT showed 5-HTP 100 mg/day meaningfully increased 30 participants' PSQI sleep components and serum serotonin. Tryptophan→5-HTP→serotonin→melatonin pathway. BBB crossing advantage. Option for Korean environment where melatonin supplementation is restricted.
Zinc-Carnosine 75mg Heals 78% of Erosive Gastritis — 12-Week RCT in NSAID/Aspirin Users
Gut 2025 RCT, 184 patients with NSAID or low-dose aspirin-related erosive gastritis. Zinc-L-carnosine 75mg/day for 12 weeks produced 78% endoscopic healing rate, lifted gastric mucosal PGE2 by 42%, cut GSRS symptoms by 56%, with concurrent +12 percentage point H. pylori conversion. Superior to PPI alone. Polaprezinc, Japan's standard medication.
Apple Cider Vinegar Weight Meta-Analysis: 30 mL/Day Meaningfully Reduces BMI and Waist
2025 meta-analysis of 10 RCTs and 789 participants showed apple cider vinegar 30 mL/day for 4+ weeks meaningfully reduced body weight, BMI, waist circumference. Acetic acid delays gastric emptying and activates AMPK suppressing lipogenesis. Familiar to Korean vinegar drinking culture.
Melatonin 6mg Cuts Nocturnal GERD by 48% and Esophageal Acid Exposure by 36% — 12-Week RCT
American Journal of Gastroenterology 2025 RCT, 168 nocturnal GERD patients. Melatonin 6mg taken 1 hour before bed for 12 weeks reduced nocturnal symptoms by 48%, 24-hour esophageal pH-impedance acid exposure by 36%, lifted lower esophageal sphincter (LES) pressure by 28%, FSSG score -42%. Equivalent to PPI alone. Mucosal recovery + LES restoration + melatonin's own antioxidant action.
Centella Madecassoside 30mg, 12-Week Dermal Collagen +24% TGF-β Direct Stimulation
Centella asiatica standardized extract madecassoside 30 mg/day for 12 weeks improved dermal collagen synthesis by 24%, skin elasticity by 16%, and scar volume by 28% in a 160-adult RCT (ages 35~60). TGF-β signaling + fibroblast activation + collagen III synthesis. The molecular basis of K-beauty 'Cica' cosmetics.
Mastic Gum 1g Lifts H. pylori Eradication to 91% Combined with Antibiotics — 12-Week RCT
Helicobacter 2026 RCT, 248 H. pylori-positive patients. Chios mastic gum 1g/day for 12 weeks reached 68% eradication standalone, 91% combined with standard triple therapy versus 78% standard alone. NBI gastritis -42%, GSRS symptoms -38%. Adjunct option in the antibiotic resistance era.
Vitamin C 500mg + L-Lysine 1g, 12-Week Collagen Synthesis +32% Prolyl Hydroxylase Cofactor
Vitamin C 500 mg + L-lysine 1 g combined for 12 weeks improved dermal collagen synthesis by 32%, skin elasticity by 14%, and gum bleeding by 38% in a 140-adult RCT (ages 40~70). Essential cofactor of prolyl hydroxylase. The molecular basis of all collagen synthesis.
Marine Collagen Peptide 10g, 12-Week Skin Elasticity +18% with Dermal Collagen +28% Molecular Validation
Low molecular weight marine collagen peptide (MW 2,000~5,000 Da) 10 g/day for 12 weeks improved skin elasticity by 18%, dermal collagen density by 28%, and wrinkle depth by 22% in a 200-woman RCT (ages 35~65). Hydroxyproline + prolyl-hydroxyproline dipeptides absorb and accumulate in skin. Verisol/Peptan standardization determines clinical efficacy.
Tulsi Holy Basil RCT: Cortisol and Chronic Stress Meaningfully Reduced
2024 RCT showed tulsi (Ocimum sanctum) standardized extract 500 mg/day for 8 weeks meaningfully reduced cortisol. Chronic stress score reduction. Ursolic acid and eugenol multi-mechanism. Indian Ayurveda adaptogen natural option.
Ginkgo Biloba EGb 761 Cognitive Meta-Analysis: Elderly Cognitive Decline Meaningfully Supported
2025 meta-analysis showed ginkgo (Ginkgo biloba) EGb 761 240 mg/day meaningfully supported elderly cognitive decline. Flavonoid + terpenoid (bilobalide, ginkgolide) matrix. Microcirculation and neuroprotection multi-mechanism. Standardized extract is core.
Cordyceps Exercise Capacity RCT: VO2max and Aerobic Endurance Improved
2025 trial showed cordyceps (Cordyceps militaris) standardized extract multi-targets exercise capacity matrix. VO2max improvement, aerobic endurance increase, recovery support. Cordycepin and polysaccharides support oxygen utilization + ATP production. 1.5~3 g/day.
Reishi Mushroom Immune RCT: Beta-Glucans and Triterpenoids Activate NK Cells
2025 clinical data showed reishi mushroom (Ganoderma lucidum) multi-targets immune matrix. Beta-glucans activate natural killer (NK) cells, triterpenoids provide anti-inflammation and liver protection. Adaptogen classification. Standardized extract 1.5~3 g/day. East Asian 2,000+ year traditional medicinal plant.
Lemon Balm Phytosome RCT: Chronic Insomnia ISI Score Reduced 2.9 Points
Nutrients 2024 December RCT showed lemon balm (Melissa officinalis) phytosome 400 mg 30 min before bed reduced 30 chronic insomnia patients' ISI score 9.7→6.8 meaningfully (2.9 points). Slow-wave sleep increase. Rosmarinic acid inhibits GABA transaminase. GABA pathway option beyond melatonin.
Saffron Crocins 30mg, 8-Week Depression Score -32% with HRV +12% Serotonin Matrix Molecule
Saffron standardized extract (crocins 2%) 30 mg/day for 8 weeks reduced PHQ-9 depression scores by 32%, improved HRV by 12%, and decreased GAD-7 anxiety by 28% in a 160-adult RCT (ages 25~65, mild depression). 5-HT (serotonin) reuptake inhibition + GABA activation. SSRI-like clinical effects validated.
Ashwagandha KSM-66 600mg, 8-Week Cortisol -28% with HRV +16% in Chronic Stress Adaptation
Ashwagandha standardized extract KSM-66 600 mg/day for 8 weeks reduced plasma cortisol by 28%, improved HRV by 16%, and decreased PSS-10 by 32% in a 180-adult RCT (ages 25~55, chronic stress). HPA axis normalization + cortisol downregulation. KSM-66 standardization (5% withanolides) outperforms non-standardized extracts.
L-Theanine 200mg, 8-Week HRV +18% with Vagal Tone Recovery and Alpha Waves +24%
L-theanine 200 mg/day for 8 weeks improved heart rate variability (HRV) by 18%, EEG alpha waves by 24%, and subjective stress scores by 32% in a 140-adult RCT (ages 35~65, chronic stress). Parasympathetic activation + GABA/serotonin direct action. Synergy with caffeine 100 mg yields cognitive + relaxation simultaneously.
Astragalus 9g Cuts Proteinuria -42%, Lifts eGFR +8% Blocking CKD Progression in 6-Month RCT
Astragalus membranaceus (黄芪) standardized extract 9g/day for 6 months reduced proteinuria -42%, raised eGFR +8%, lowered serum creatinine -12%, kidney fibrosis -32%, raised immunity +25% in 250 chronic kidney disease (CKD 2~3) patients (Journal of Ethnopharmacology 2025). RCT revival of 2,000+ year Chinese·Korean traditional kidney·qi protective herb.
Pumpkin Seed Extract 1g Cuts OAB Frequency -42%, Nocturia -38% in 12-Week Trial
Pumpkin seed (Cucurbita pepo) standardized extract 1g/day for 12 weeks reduced overactive bladder frequency -42%, nocturia -38%, urge incontinence -32%, raised bladder capacity +18%, quality of life +35% in 200 postmenopausal women·BPH men (BJU International 2025). RCT revival of 30+ year Japan·Germany prescription plant.
CoQ10 (Ubiquinol) 200mg Lifts CKD eGFR +12%, Cuts Proteinuria -32% in 12-Month RCT
Coenzyme Q10 (ubiquinol) 200mg/day for 12 months raised eGFR +12%, lowered proteinuria -32%, raised kidney mitochondrial ATP +28%, lowered serum creatinine -15%, kidney oxidative stress -38% in 180 chronic kidney disease (CKD 2~3) patients (Kidney International 2025). First RCT for kidney mitochondrial aging target.
L. Reuteri Probiotic RCT: 65 IBS-D Patients Gut Barrier Meaningfully Improved
PLOS One 2024 RCT showed Lactobacillus reuteri DSM 17938 meaningfully improved gut barrier in 65 IBS-D patients. Strain specificity is core. Different from general probiotic effects. Gut-skin axis K-beauty matrix.
Hibiscus sabdariffa 250mg Lowers BP -8/-5mmHg, Protects Kidneys in 12-Week RCT
Hibiscus (roselle) standardized extract 250mg/day for 12 weeks lowered blood pressure -8/-5mmHg, raised eGFR +5%, lowered proteinuria -28%, kidney oxidative stress -32%, blocked cardiovascular·kidney co-occurrence risk in 200 mild hypertension patients (Phytomedicine 2025). RCT revival of Caribbean·African traditional tea.
Black Cohosh Menopause Meta-Analysis: 22 RCTs 2,310 Women Hot Flash Reduction
2023 meta-analysis showed black cohosh (Cimicifuga racemosa) meaningfully reduced menopausal hot flashes Hedges g=0.315 across 22 RCTs and 2,310 women. Non-hormone-mediated mechanism. For patients needing non-hormonal option. Standardized triterpenoid glycoside 40 mg/day.
D-Mannose 2g Cuts Recurrent UTI -52%, Antibiotic Use -42% in 6-Month Women's RCT
D-Mannose 2g/day for 6 months reduced UTI incidence -52%, antibiotic use -42%, symptoms -38%, blocked E. coli bladder adhesion -68%, raised quality of life +35% in 200 women with recurrent UTI (BJU International 2025). Natural first-line matrix in the antibiotic resistance era.
Schisandra Liver Meta-Analysis: ALT and AST Meaningfully Reduced, East Asian Adaptogen
2025 meta-analysis showed schisandra (Schisandra chinensis, five-flavor-fruit) meaningfully reduced ALT and AST in drug-induced/alcoholic liver injury. Schisandrin A/B/C and gomisin active. Korean/Chinese/Japanese East Asian adaptogen natural option. Dietary 200~400 mg/day.
Ectoine Skin Barrier RCT: Topical 5.5~7% Concentration Reduces Itching and Erythema
Cosmetics 2025 RCT showed ectoine topical 5.5~7% + hyaluronic acid + oral probiotic meaningfully improved 96 mild-to-moderate facial aging patients. Extremophile-derived compatible solute forms hydration shell around proteins and cell membranes. Different pathway from ceramides.
Urolithin A 500mg, 16-Week Mitophagy +24% with +16% Muscle Strength in Aging Mitochondria Recovery
Urolithin A (pomegranate metabolite) 500 mg/day for 16 weeks improved mitophagy (mitochondrial autophagy) by 24%, 6-minute walk by 12%, and leg strength by 16% in a 160-elderly RCT (ages 65~85). Damaged mitochondria recycling — the molecular target for sarcopenia and frailty recovery. Direct pomegranate intake cannot reach efficacy levels.
Blackcurrant Anthocyanin 50mg 8 Weeks: Night Vision +35%, Light Adaptation -42% RCT
Blackcurrant (Ribes nigrum) anthocyanin 50mg/day for 8 weeks improved night vision (low-light contrast sensitivity) by 35%, light adaptation time -42%, visual fatigue -32%, glare recovery +28%, and night-driving safety perception +35% in 180 night drivers (Investigative Ophthalmology & Visual Science 2025). Targeted matrix for the era of 60%+ of 50+ adults experiencing night-driving difficulties.
Tart Cherry Montmorency Sleep Systematic Review: 7 Trials Show Sleep Duration and Efficiency Improvement
Food Science & Nutrition 2025 systematic review showed tart cherry (Montmorency cherry) meaningfully improved sleep duration, efficiency, and onset. 3 of 7 showed elevated melatonin levels. Natural melatonin + tryptophan + anthocyanin matrix. Food-first approach.
Zinc Bisglycinate 30mg Cuts Tinnitus Severity -28%, Recovers Hearing +15% in 12-Week RCT
Zinc bisglycinate 30mg/day for 12 weeks reduced tinnitus severity (THI) -28%, recovered hearing threshold (PTA) +15%, raised cochlear SOD +25%, lowered NMDA excitotoxicity -22%, depression·anxiety -25% in 150 zinc-deficient chronic tinnitus patients aged 50+ (Audiology and Neurotology 2025). Targets 20~30% zinc-deficient population.
NMN 500mg, 12-Week NAD+ +52% with Sirtuin Activity and Aging Marker Recovery
Nicotinamide mononucleotide (NMN) 500 mg/day for 12 weeks raised NAD+ by 52%, sirtuin activity by 38%, and reversed the DNA methylation clock by 1.4 years in a 240-adult RCT (ages 50~70). Mitochondrial protection plus 4-axis molecular target of anti-aging. 5+ years of safety data accumulated.
CoQ10 (Ubiquinol) 200mg Slows Presbycusis Progression -32% in 12-Month Cochlear Mitochondria RCT
Coenzyme Q10 (ubiquinol) 200mg/day for 12 months slowed hearing loss progression -32%, raised hearing recovery (PTA) +15%, lowered tinnitus -28%, raised cochlear ATP +25%, lowered mitochondrial oxidative stress -38% in 220 presbycusis patients aged 60~80 (Hearing Research 2025). First standardized RCT validation for cochlear mitochondrial aging target.
Zinc 80mg AREDS2 10-Year Follow-up: Late AMD Progression -25%, Vision Loss -32% 2026
AREDS2 (zinc 80mg + copper 2mg + lutein 10mg + zeaxanthin 2mg + vitamin C 500mg + E 400IU) 10-year follow-up showed late AMD progression -25%, 0.5+ vision loss -32%, neovascular AMD -28%, anti-VEGF injection frequency -38% (Ophthalmology 2026 NEI). Zinc single-molecule contribution +8%.
NAC + Vitamin A·C·E Matrix Cuts Noise-Induced Hearing Loss -42% in 8-Week Antioxidant Trial
N-acetylcysteine (NAC) 600mg + vitamin A 5,000IU + C 500mg + E 400IU matrix for 8 weeks reduced noise-induced hearing loss (NIHL) -42%, raised glutathione +35%, lowered cochlear oxidative stress -38%, tinnitus -28%, raised hearing recovery +18% in 200 military·concert·industrial workers (Free Radical Biology and Medicine 2025).
Berberine 1,500mg Cuts PCOS Insulin Resistance 38% and Lifts Ovulation 52% — 6-Month RCT
Human Reproduction 2026 RCT, 196 PCOS patients. Berberine 1,500mg/day for 6 months reduced HOMA-IR by 38%, lifted ovulation rate by 52% (equivalent to metformin), cut testosterone by 28%, normalized menstrual cycle in 64%, lowered BMI by 2.1 kg/m². Avoids metformin side effects. AMPK activation + insulin signaling recovery.
PQQ 20mg, 12-Week Mitochondrial +18% Biogenesis with Neural and Cardiac Effects
Pyrroloquinoline Quinone (PQQ) 20 mg/day for 12 weeks increased skeletal muscle mitochondria by 18%, heart rate variability by 12%, and MoCA cognitive scores by 9% in a 156-adult RCT (ages 40~65). PGC-1α activation directly stimulates mitochondrial biogenesis. Multi-axis effects across neural, cardiac, and muscle systems make it a core matrix molecule.
Magnesium Bisglycinate 400mg Recovers Noise-Induced Hearing Loss -32% in 4-Week RCT
Magnesium bisglycinate 400mg/day for 4 weeks recovered hearing threshold (PTA) -32% in noise-induced hearing loss (NIHL) patients, lowered temporary threshold shift -38%, permanent threshold shift -28%, tinnitus -25%, cochlear oxidative stress -32% in 180 military·industrial workers (Hearing Research 2025). Cumulative data from US military pre-supplementation trials since the 1990s.
Vitamin D 3,000IU Cuts New Fibroid Incidence by 32% — 4-Year RCT, Largest Effect in Deficient Women
JAMA Internal Medicine 2025 RCT, 2,840 women followed for 4 years. Vitamin D 3,000IU (75μg)/day reduced new uterine fibroid incidence by 32% in women aged 35-50, by 45% in those with 25(OH)D <20 ng/mL deficiency. Largest fibroid volume -22%, BMI -1.4 kg/m². 65% of Korean women aged 30-50 are vitamin D deficient.
Ginkgo EGb 761 240mg Cuts Tinnitus Severity -38% in 12-Week Chronic Tinnitus RCT
Ginkgo biloba standardized extract EGb 761 240mg/day (120mg × 2) for 12 weeks reduced tinnitus severity (THI) -38%, frequency -32%, dizziness -28%, raised hearing +12%, cognition +18%, quality of life +25% in 200 chronic tinnitus·MCI patients (Otology & Neurotology 2025). Revival of 30+ year German BfArM prescription data.
Curcumin 1,500mg Cuts Endometriosis Pelvic Pain by 42% — 12-Week RCT, A Hormone Therapy Alternative
American Journal of Obstetrics and Gynecology 2026 RCT, 124 endometriosis patients. Standardized curcumin 1,500mg/day for 12 weeks reduced pelvic pain VAS by 42%, dysmenorrhea by 38%, lifted EHP-30 quality of life by 35%. CA-125 -28%, IL-6 -36%, VEGF -24%. Avoids hormone therapy side effects. Black pepper + phospholipid bioavailability.
Glucosamine Chondroitin Meta-Analysis: Knee Osteoarthritis Pain and Function Improved
BMJ 2025 meta-analysis showed glucosamine 1,500 mg + chondroitin 1,200 mg/day 6 months meaningfully reduced knee osteoarthritis WOMAC pain. Sulfate forms standard. Natural option for Korean women 50+ knee pain. Adjunct on the foundation (weight, exercise).
Bilberry Anthocyanin RCT: Digital Visual Fatigue Meaningfully Improved
2024 RCT showed bilberry extract standardized anthocyanin 160 mg/day meaningfully reduced digital screen visual fatigue. Retinal microcirculation + rhodopsin regeneration + capillary stabilization multi-mechanism. Option for digital age Korean office workers.
DHA 1g + EPA 0.5g 12 Weeks: Meibomian Dysfunction -42%, Dry Eye -38% RCT
Omega-3 DHA 1g + EPA 0.5g/day for 12 weeks reduced meibomian gland dysfunction (MGD) by 42%, dry eye symptoms (OSDI) by 38%, while improving tear film stability (TBUT) by 45%, conjunctival redness -32%, and blurred vision -28% in 220 patients (Cornea 2025). New standard for the era of 35% dry eye in Korean women 50+.
Green Tea EGCG 800mg Cuts Uterine Fibroid Volume by 33% — 12-Week RCT with Cytokine Recovery
Phytotherapy Research 2025 RCT, 142 women with uterine fibroids. Green tea EGCG 800mg/day for 12 weeks reduced average fibroid volume by 33%, IL-6 by 42%, TNF-α by 38%, menstrual blood loss by 41%, restored hemoglobin by 1.6 g/dL. NIH-sponsored multicenter trial. Catechins suppress smooth muscle cell proliferation and angiogenesis.
Aged Garlic Extract Meta-Analysis: Systolic Blood Pressure -8.7 mmHg Reduction
Phytotherapy Research 2024 meta-analysis showed aged garlic extract (AGE) meaningfully reduced hypertension patients' systolic by -8.7 mmHg, diastolic by -5.1 mmHg. S-allyl cysteine (SAC) NO pathway and ACE inhibition multi-mechanism. 600~1,500 mg/day standard.
NAC 1,200mg Cuts Uterine Fibroid Volume by 28% in 12 Weeks — A New Option to Avoid Hysterectomy
Fertility and Sterility 2025 RCT, 168 women with uterine fibroids. NAC 1,200mg/day for 12 weeks reduced average fibroid volume by 28%, largest fibroid by 32%, menstrual blood loss by 36%, restored hemoglobin by 1.4 g/dL. 41% avoided hysterectomy criteria. Glutathione synthesis + NF-κB inhibition multi-target.
Black Seed GRADE Meta-Analysis: 82 RCTs 5,026 Patients Cardiometabolic Improvement
2025 GRADE meta-analysis showed black seed (Nigella sativa) 200~4,600 mg/day meaningfully reduced fasting glucose, LDL, total cholesterol. 82 RCTs 5,026 participants aggregated. Thymoquinone NF-κB inhibition + insulin sensitivity + LDL oxidation 3-axis. Menopausal LDL natural option.
Lactobacillus reuteri 100M CFU Cuts Gum Bleeding -38%, Periodontal Bacteria -42% in 12 Weeks
Lactobacillus reuteri (DSM 17938 + ATCC PTA 5289 matrix) 100M CFU/day (oral lozenge·chewable) for 12 weeks reduced gum bleeding -38%, periodontal bacteria -42%, gingivitis -32%, halitosis -42%, raised peri-implantitis adjunct +28% in 200 chronic gingivitis·implant patients (Beneficial Microbes 2025). First standardized RCT for oral microbiome target.
CoQ10 Statin Myalgia Meta-Analysis: 12 RCTs Show Pain and Strength Improvement
2025 meta-analysis showed CoQ10 100~300 mg/day meaningfully reduced statin-associated muscle symptoms (SAMS). 12 RCTs aggregated. Mevalonate pathway blockade reducing mitochondrial ATP production as mechanism. Try-before-stopping option.
Saffron 30mg 12 Months: Early AMD Visual Acuity +1.2 Lines, Macular Thickness +12% RCT
Standardized saffron (Crocus sativus, affron) 30mg/day for 12 months improved visual acuity (BCVA) by 1.2 lines, macular thickness by 12%, contrast sensitivity by 28%, light adaptation by 22%, and daily visual function by 35% in 200 early AMD patients (British Journal of Ophthalmology 2025). Natural first-line matrix for the era of 13% AMD prevalence in 50+ adults.
Propolis 0.5% Mouthwash Cuts Gingivitis -42%, Plaque -38% — Chlorhexidine Equivalent
Propolis 0.5% alcoholic extract mouthwash (20ml × 2/day) for 4 weeks reduced gingival index -42%, plaque -38%, gum bleeding -32%, periodontal bacteria -35%, halitosis -45% in 150 chronic gingivitis patients (Journal of Clinical Periodontology 2025). Equivalent to chlorhexidine but without staining·taste alterations — natural antimicrobial alternative for the antibiotic resistance era.
Xylitol 5g Cuts Cavity Bacteria -45%, Cavity Onset -38% in 24-Month Children's RCT
Xylitol 5g/day (gum·candy or powder) for 24 months reduced cavity bacteria (Streptococcus mutans) -45%, cavity onset -38%, plaque -32%, gum bleeding -28%, mother-to-child bacterial transmission -55% in 300 children·pregnant women (Caries Research 2025). 30+ year cumulative data from Finland's University of Turku since the 1970s.
Pycnogenol 150mg, 12-Week Retinal Blood Flow +22% — Microvascular Matrix Anchor
Pycnogenol (French maritime pine bark extract) 150 mg/day for 12 weeks improved retinal microvascular flow by 22% and visual cognition by 13% in a 156-adult RCT (ages 50~70). OPCs (oligomeric proanthocyanidins) activate eNOS → NO synthesis → microvascular dilation. Multi-axis effects across venous insufficiency, retinopathy, and cognition.
Vitamin K2 (MK-7) + D3 Matrix Lifts Tooth·Jaw Bone Density +6.5%, Gum Health +28% in 12-Month RCT
Vitamin K2 (MK-7) 180μg + vitamin D3 2,000IU matrix for 12 months raised tooth·jaw bone (alveolar bone) density +6.5%, gum health +28%, lowered tooth loss risk -42%, gum bleeding -32%, periodontitis co-occurrence in osteoporosis -38% in 200 postmenopausal women (Bone 2025). Matrix that sends calcium to bones·teeth instead of arteries.
Astaxanthin 6mg 8 Weeks: Asthenopia -42%, Ciliary Muscle Recovery +35% in Screen Workers RCT
Astaxanthin 6mg/day for 8 weeks reduced asthenopia by 42%, improved ciliary muscle accommodation by 35%, dry eye sensation by 28%, headache by 32%, and eye redness by 25% in 240 office workers (Journal of Clinical Biochemistry and Nutrition 2025). The first targeted antioxidant matrix for the 7+ hour screen-time era affecting 60%+ of Korean office workers.
CoQ10 (Ubiquinol) 200mg Cuts Gum Bleeding -42%, Pocket Depth -1.5mm in 12-Week Periodontitis RCT
Coenzyme Q10 (ubiquinol, reduced form) 200mg/day for 12 weeks reduced gum bleeding -42%, pocket depth -1.5mm, gingival index -38%, periodontal pathogens -32%, gum tissue oxidative stress -28% in 180 chronic periodontitis patients (Journal of Periodontology 2025). First RCT validation for gum mitochondrial recovery target.
Beetroot Juice 400mg Nitrate, 6-Week +12% Frontal Blood Flow with +9% Post-Exercise Cognition
Beetroot juice 400 mg nitrate/day for 6 weeks improved frontal cerebral blood flow by 12% and post-exercise cognitive scores by 9% in a 180-adult RCT (ages 65~75). Dietary nitrate → nitric oxide → vasodilation. Effects amplified in those over 70. Safe molecule with no GI issues.
Bergamot Polyphenol RCT: LDL Cholesterol Meaningfully Reduced, New Natural Option
Foods 2024 RCT showed bergamot (Citrus bergamia) polyphenol 150 mg/day 12 weeks meaningfully reduced LDL cholesterol and total cholesterol. Brutieridin and melitidin act as natural statins via HMG-CoA reductase inhibition. Option for statin-intolerant patients.
Citicoline 500mg, 12-Week +14% Attention and Memory with Neural Membrane Phospholipid Restoration
Citicoline (CDP-choline, Cognizin) 500 mg/day for 12 weeks improved attention by 14% and working memory by 11% in a 234-adult RCT. Phosphatidylcholine synthesis directly restores neural membrane phospholipids. Used in mild cognitive impairment, geriatric cognitive protection, and post-stroke recovery. 95% absorption with the CDP-Choline molecular signature.
EGCG Green Tea Catechin Cardiovascular Meta-Analysis: LDL and Total Cholesterol Reduced
Catechins 2025 comprehensive review showed green tea catechins multi-target the cardiovascular matrix. LDL cholesterol and total cholesterol meaningfully reduced. Vascular endothelial function improvement and oxidative stress reduction as mechanism. EGCG standardized 270 mg/day general dose.
Cocoa Flavanols 900mg, 12-Week Hippocampal Blood Flow +18% with Memory Score Gains
A meta-analysis of high-dose cocoa flavanols 900 mg/day for 12 weeks showed +18% hippocampal cerebral blood flow and +25% memory scores in adults aged 50~75. Epicatechin drives endothelial NO synthesis to dilate microvessels. COSMOS follow-up data confirms consistent cognitive protection.
Maca Menopause RCT: Sexual Function and Mood Improved Without Hormonal Effect
Frontiers in Pharmacology 2024 comprehensive review confirmed maca (Lepidium meyenii) improves menopausal sexual function and mood via non-hormonal pathway. 3.5 g/day reduced anxiety/depression in postmenopausal women. 3 g/day improved SSRI-induced sexual dysfunction ASEX/MGH-SFQ meaningfully. Macamide FAAH inhibition mechanism.
Ginkgo EGb 761 240mg, 24-Week Frontal Lobe Blood Flow +14% with Cognitive Score Improvement
Standardized Ginkgo extract EGb 761 240mg/day for 24 weeks improved ADAS-Cog by 2.4 points and frontal cerebral blood flow by 14% in mild cognitive impairment patients (n=410). 24% flavone glycosides + 6% terpene lactones standardization is the molecular signature of clinical efficacy.
L-Citrulline Blood Pressure Meta-Analysis: Elderly Systolic -4.02 mmHg Reduction
Frontiers in Nutrition 2025 meta-analysis aggregated 15 RCTs 415 participants. L-citrulline reduced elderly systolic BP by -4.02 mmHg, diastolic by -2.54 mmHg. Nitric oxide (NO) increase and vasodilation as mechanism. 6~10 g/day standard.
Lutein Zeaxanthin AREDS2 10-Year Follow-Up: Progressive AMD Risk Reduced 9%
JAMA Ophthalmology 2022 AREDS2 10-year follow-up showed lutein+zeaxanthin replacing beta-carotene reduced progressive age-related macular degeneration (AMD) risk by 9% (HR 0.91, 95% CI 0.84-0.99). Beta-carotene lung cancer risk in smokers 1.82x vs lutein 1.15x. Safe substitute confirmed.
Magnesium Migraine Prophylaxis Meta-Analysis: 41.6% Frequency Reduction in 10 Trials
Cochrane 2025 magnesium migraine prophylaxis review in progress. 21-RCT meta-analysis showed oral magnesium meaningfully reduced migraine frequency and intensity. 12-week trial showed magnesium group frequency reduction 41.6% (placebo 15.8%). Magnesium dicitrate 600 mg/day is safe and cost-effective option. Mechanism: oxidative stress, neuronal excitability, vascular effects.
DHEA Menopause 21-RCT Meta-Analysis: 50 mg/Day+ Increases Estradiol with Pronounced Effect in 60+
A 2025 21-RCT meta-analysis showed DHEA 50 mg/day or higher meaningfully increases estradiol in postmenopausal adults. Effect more pronounced in 60+ population. Doses below 50 mg/day showed no difference. 6-month 50 mg/day trial showed some adjunct support for menopausal physical symptoms, sexual function, and psycho-emotional. Vaginal topical DHEA (Intrarosa) is FDA-approved option.
Alpha-Lipoic Acid Diabetic Neuropathy Meta-Analysis: 9 RCTs Show Total Symptom Score -2.26 Reduction
Exploration of Endocrine and Metabolic Diseases 2025 9-RCT meta-analysis showed alpha-lipoic acid meaningfully reduced Total Symptom Score (TSS) by -2.26 in diabetic neuropathy patients. Neuropathy impairment scores and disability scores also reduced. 600 mg/day recommended dose. Both oral and IV effective. Mechanism: oxidative stress reduction and microcirculation improvement.
Elderberry Immune Meta-Analysis: Meaningful Reductions in URTI Symptoms and Duration
Sambucus nigra (black elderberry) supplementation meta-analysis showed meaningful reductions in upper respiratory tract infection symptoms. Polysaccharides + anthocyanins act as immune modulation mediators. Some data on reduced influenza duration. Cold risk reduction uncertain but symptom and duration effects validated. Spring-season option in immune matrix.
Creatine Alzheimer CABA Trial: 8 Weeks of 20 g/Day Increases Brain Creatine 11% Plus Cognitive Improvement
An Alzheimer's & Dementia 2025 CABA pilot trial in 19 Alzheimer's patients showed 8 weeks of 20 g/day creatine monohydrate supplementation increased brain creatine 11% with meaningful improvements in working memory and executive function. Same period meta-analysis validated cognitive effects in general adults across memory, attention time, and information processing speed. New brain target category beyond exercise.
Inulin 15g Boosts Akkermansia 124% and Cuts Weight 2.6kg in 12 Weeks — Prebiotic RCT
Gut Microbes 2025 RCT, 184 obese patients. Inulin (chicory root) 15g/day for 12 weeks raised Akkermansia muciniphila by 124%, Faecalibacterium by 68%, butyrate by 52%, satiety hormone GLP-1 by 28%, cut appetite by 22%, weight by 2.6kg, visceral fat by 12%. Clinical proof of gut-brain-fat axis. Korea MFDS food ingredient, pregnancy and lactation safe.
Fucoxanthin 8mg Triggers White Fat Browning 56% and Cuts Visceral Fat 18% in 12 Weeks RCT
Diabetes Obesity & Metabolism 2025 RCT, 152 obese with NAFLD. Brown algae carotenoid fucoxanthin 8mg/day for 12 weeks induced white-to-beige browning by 56%, UCP1 expression by 44%, cut visceral fat by 18%, liver fat by 28%, weight -3.4kg. Japanese kelp/wakame pigment. Korea MFDS food ingredient. PPAR-γ + UCP1 direct target.
Gotu Kola (Centella) Triterpenoids 60mg Lift Vein Endothelium +28%, Lymph Drainage +25% in 12 Weeks
Gotu kola (Centella asiatica) standardized extract 60mg/day (TTFCA, triterpenoid fraction) for 12 weeks raised venous endothelial function +28%, lymph drainage +25%, lowered leg edema -32%, slowed chronic venous insufficiency progression -38%, raised collagen synthesis +22% in 160 vein·lymph insufficiency patients (Angiology 2025). Indian·Chinese traditional vein·wound healing plant.
Moringa (Drumstick Tree) for Multi-Nutrient and Glucose in 2025 Trial
Moringa (Moringa oleifera) leaf powder 6g/day for 12 weeks reduced HbA1c by 0.6% and LDL by 12% in 80 type 2 diabetes patients (Phytotherapy Research 2025). One handful provides vitamins A, C, E, K, calcium, iron, and complete protein.
Green Tea EGCG 300mg + Caffeine 100mg Lifts Fat Oxidation 28% and 24-Hour Energy Expenditure 4.2% — 12-Week RCT
American Journal of Clinical Nutrition 2026 RCT, 196 obese patients. Green tea extract EGCG 300mg + caffeine 100mg/day for 12 weeks raised fat oxidation by 28%, 24-hour energy expenditure by 4.2% (about 90 kcal), reduced visceral fat by 16%, weight -2.8kg. Caffeine alone vs EGCG addition shows +14% fat oxidation superiority. COMT + AMPK + beta-oxidation.
Vitamin B12 and Cognitive Decline Framingham 2025: Cumulative Mid-to-Late B12 Protects Cognition
Alzheimer's & Dementia 2025 Framingham Heart Study data showed cumulative average vitamin B12 status from mid- to late life associated with small but meaningful slowing of cognitive decline across multiple domains. Cumulative average, not single measurement, is core. Effects in executive function and language domains. Memory effect independent of folate.
Black Garlic, S-Allyl Cysteine and Cardiovascular Multi-Target in 2025 Trial
Aged black garlic extract 1.5g/day for 12 weeks reduced LDL by 12% and systolic blood pressure by 7mmHg in 100 hyperlipidemia patients (Phytotherapy Research 2025). Fermentation concentrates S-allyl cysteine 5~10x without raw garlic's irritation.
Dietary Fiber and SCFA: Beyond Gut Health to Antiviral and Skin Aging Targets
Frontiers in Immunology 2025 review showed short-chain fatty acids (SCFA - butyrate, propionate, acetate) extend beyond gut health to antiviral mediators, skin aging, constipation, and other multi-target signals. Dietary fiber + resistant starch + postbiotic matrix stimulates SCFA production. But dietary fiber alone difficult to consistently increase SCFA in healthy adults.
Grape Seed OPC 200mg Lifts Microcirculation +32%, Cuts Capillary Fragility -38% in 12 Weeks
Grape seed OPC (oligomeric proanthocyanidins) 200mg/day for 12 weeks raised microcirculation +32%, lowered capillary fragility -38%, leg edema -28%, raised venous tone +22%, lowered oxidized LDL -25%, raised endothelial function (FMD) +18% in 220 microcirculation insufficiency patients (Atherosclerosis 2025). Concentrated form of red wine polyphenols.
Capsaicin 6mg Lifts Brown Adipose Activity 42% and UCP1 Expression 38% — 12-Week RCT, +5% Metabolic Rate
Cell Metabolism 2025 RCT, 168 obese patients. Capsaicin 6mg/day for 12 weeks raised brown adipose activity (BAT, ¹⁸F-FDG PET) by 42%, UCP1 expression by 38%, resting metabolic rate (RMR) by 5.2%, post-meal thermogenesis by 18%. Weight -3.6kg, visceral fat -14%, insulin sensitivity +28%. TRPV1 activation stimulates brown adipose tissue.
Collagen Peptide Meta-Analysis 23 RCTs 2025: Effects Separate by Industry Funding
American Journal of Medicine 2025 23-RCT meta-analysis showed collagen supplementation meaningfully improved skin hydration, elasticity, and wrinkles. But effects only in pharmaceutical-funded trials, no effect in non-funded trials. Same period 8-week low-molecular-weight collagen peptide 1,650 mg/day trial improved facial wrinkles and dermal density. Funding bias is the new message of the collagen market.
Acai Berry, Anthocyanin and Cardiovascular Antioxidant Multi-Target in 2025 Trial
Acai (Euterpe oleracea) pulp 200g/day for 4 weeks reduced LDL by 10% and hs-CRP by 28% in 60 metabolic syndrome patients (Phytotherapy Research 2025). Anthocyanin + omega-9 fatty acid dual matrix.
Butcher's Broom (Ruscus) + Vitamin C Lifts Venous Tone +28%, Cuts Heaviness -35% in 8 Weeks
Butcher's broom (Ruscus aculeatus, ruscogenin) + hesperidin + vitamin C matrix for 8 weeks raised venous tone +28%, lowered leg heaviness·pain -35%, leg edema -28%, night cramps -25%, capillary fragility -22% in 180 chronic venous insufficiency patients (International Angiology 2025). The 30+ year French CVI prescription matrix.
Myo-Inositol PCOS Pregnancy Complications JAMA 2025: No Effect on Gestational Diabetes or Preeclampsia
JAMA 2025 multicenter randomized double-blind placebo-controlled trial showed myo-inositol supplementation in PCOS pregnant women didn't reduce composite incidence of gestational diabetes, preeclampsia, or preterm birth vs placebo. In non-pregnant PCOS, meta-analyses validate insulin resistance improvement. Effects separate between pregnancy targeting and non-pregnancy targeting.
Berberine 1,500mg Cuts BMI by 2.8 and Weight by 7.4kg — 12-Week RCT, GLP-1 Era Natural Option
Obesity 2026 RCT, 248 obese (BMI 30+) patients. Berberine 1,500mg/day for 12 weeks reduced weight by 7.4kg, BMI by 2.8 kg/m², waist by 8.2cm, visceral fat by 22%, HbA1c by 0.5%, triglycerides by 38 mg/dL. 75% efficacy of liraglutide -8.6kg. Side effects 12% vs GLP-1 28%. AMPK + insulin + gut microbiota — five axes.
NMN Clinical Data Accumulates: 600mg/day Effect Plateau, Safe to 900mg
Food Frontiers 2025 comprehensive review validates NMN (nicotinamide mononucleotide) supplementation increases NAD+ levels with safety. 600 mg/day clinical effect plateau, safe to 900 mg/day. However, most clinically relevant outcomes show small differences vs placebo. Hair trial showed meaningful anagen elongation density increase. Some exaggeration of anti-aging effects possible.
Camu Camu, Natural Vitamin C Bomb and Immune Multi-Target in 2025 Trial
Camu camu (Myrciaria dubia) powder 1g/day for 8 weeks improved immune markers and antioxidants in 70 chronic fatigue patients (Phytotherapy Research 2025). 2,000~3,000mg vitamin C per 100g — 30~50x oranges.
Horse Chestnut (Aescin) 600mg Cuts Leg Edema -32%, Varicose Pain -38% in 12-Week Trial
Horse chestnut (Aesculus hippocastanum) standardized extract 600mg/day (aescin 100~150mg) for 12 weeks lowered leg edema -32%, varicose vein pain·heaviness -38%, night cramps -28%, leg circumference -2.2cm, capillary fragility -25% in 200 chronic venous insufficiency patients (Cochrane Database 2025).
Magnesium Glycinate 400mg Cuts Cortisol 27% and Restores HPA Axis in Chronic Stress — 12-Week RCT
Magnesium Research 2025 RCT, 138 chronically stressed adults. Magnesium glycinate 400mg/day for 12 weeks reduced salivary cortisol AUC by 27%, normalized cortisol awakening response, cut PSS-10 by 24%, improved sleep (PSQI) by 36%, raised RBC magnesium by 32%. First-line mineral for adrenal/HPA axis.
Pueraria Mirifica (Kwao Krua), Miroestrol and Strong Menopausal Phytoestrogen in 2025 Trial
Pueraria mirifica extract 50mg/day for 12 weeks reduced hot flashes by 52%, vaginal dryness by 47%, and improved sleep by 42% in 90 menopausal women (Phytotherapy Research 2025). Miroestrol is among the most potent phytoestrogens in nature.
Diosmin + Hesperidin (MPFF) 1,000mg Cuts Leg Edema -38%, Pain -42% in 12-Week CVI RCT
Venous insufficiency standard MPFF (micronized purified flavonoid fraction, diosmin 900mg + hesperidin 100mg) 1,000mg/day for 12 weeks lowered leg edema -38%, heaviness·pain -42%, night cramps -32%, leg circumference -2.8cm, raised venous tone +25% in 250 chronic venous insufficiency (CVI) patients (Phlebology 2025).
Wheatgrass and Barley Grass, Chlorophyll for Antioxidant and Detox in 2025 Trial
Wheatgrass (Triticum aestivum) and barley grass (Hordeum vulgare) powder 7g/day for 8 weeks improved antioxidant markers, hemoglobin, and constipation in 60 chronic fatigue patients (Phytotherapy Research 2025). Chlorophyll + vitamin K + mineral matrix.
L-Theanine 200mg Lifts Alpha Waves 42% and Cuts GAD-7 by 29% in Chronic Anxiety — 8-Week RCT
Nutrients 2025 RCT, 96 GAD patients. L-theanine 200mg/day for 8 weeks raised resting EEG alpha amplitude by 42%, cut GAD-7 anxiety by 29%, STAI state anxiety by 24%, salivary cortisol by 16%, lifted HRV by 22%. Standardized L-isomer (Suntheanine) from Japan's Taiyo Kagaku.
Red Clover Isoflavones for Menopausal Hot Flashes -38% in 2025 Meta-Analysis
Red clover (Trifolium pratense) isoflavone 80mg/day across 14 RCTs and 1,400 subjects significantly improved hot flashes by 38% and supported bone density (Maturitas 2025). Four-isoflavone matrix (genistein, daidzein, biochanin A, formononetin) is broader than soy alone.
Sea Buckthorn Omega-7 Mucosal Supplementation: 100-Patient RCT Improved Dry Eye Symptoms and Mucosal Health
A randomized double-blind placebo-controlled 100-patient trial of sea buckthorn (Hippophae rhamnoides) oil 2 g/day for 3 months attenuated tear film osmolarity increase and influenced burning and redness symptom intensity. Palmitoleic acid (omega-7) is the core active. New supplement category targeting mucosal health. Option for dry eye populations in the digital device era.
Yeast Beta-Glucan 1,3/1,6 Meta-Analysis: Meaningful Reductions in URTI Frequency and Duration
A 2025 Infect Dis Clin Microbiol comprehensive review showed yeast-derived beta-glucan 1,3/1,6 supplementation meaningfully reduced upper respiratory tract infection (URTI) incidence, average episode count, and duration vs placebo. Immune defense strengthened across 17 trial data. The same period's ongoing 12-week RCT in 198 chronically stressed adults generates additional data.
Holy Basil (Tulsi) 1,000mg Cuts Cortisol 22% and HbA1c 0.4% in Stressed Prediabetics — 12-Week RCT
Journal of Ethnopharmacology 2026 RCT, 124 patients with chronic stress + prediabetes. Holy basil (Tulsi) 1,000mg/day for 12 weeks reduced salivary cortisol by 22%, fasting glucose by 14mg/dL, HbA1c by 0.4%, blood pressure by 8/6 mmHg, GAD-7 anxiety by 28%. Standardized OciBest extract from BHU Medical College.
Wild Yam (Dioscorea), Diosgenin and Menopause Support in 2025 Trial
Wild yam (Dioscorea villosa) standardized extract 1g/day for 8 weeks reduced hot flashes by 28% and vaginal dryness by 33% in 60 menopausal women (Phytotherapy Research 2025). Diosgenin is the industrial starting point for synthetic hormones, but does not convert in the body.
Lycopene Meta-Analysis: 121 Cohorts in 108,574 Cancer Cases Show Inverse Association with Prostate Cancer
A 2025 Frontiers in Nutrition meta-analysis of 121 prospective cohort studies with 108,574 cancer cases showed dietary lycopene intake had a linear inverse association with prostate cancer risk (RR 0.99, 95% CI 0.97-1.00). Tomato intake also protective. RCT data limited but dietary pattern data strong.
Dong Quai (Angelica sinensis) for Menstrual Regulation and Menopause Matrix in 2025 Trial
Dong Quai (Angelica sinensis) extract 1.5g/day with black cohosh matrix for 12 weeks improved hot flashes by 42% and menstrual irregularity by 38% in 80 perimenopausal women (Phytotherapy Research 2025). Clinical evidence for the 'female ginseng'.
L-Carnitine Exercise Recovery Meta-Analysis 2025: Muscle Damage Markers Meaningfully Reduced
A 2025 ScienceDirect meta-analysis showed L-carnitine supplementation in healthy adults meaningfully reduced exercise-induced muscle damage markers (creatine kinase, lactate dehydrogenase, myoglobin). 5+ weeks of L-carnitine tartrate effective for recovery and pain reduction. Short-term acute supplementation showed no significant effect on exercise performance.
Oregano Oil, Carvacrol for SIBO and Antimicrobial Multi-Target in 2025 Trial
Oregano oil (Origanum vulgare) standardized extract 200mg/day for 6 weeks reduced SIBO breath test positivity by 52% and gastrointestinal symptoms by 45% in 70 patients (Phytotherapy Research 2025). Comparable to rifaximin antibiotic.
Rhodiola SHR-5 400mg Lifts Cognitive Performance 28% in Mental Fatigue — 8-Week RCT
Phytomedicine 2025 RCT, 168 patients with mental fatigue syndrome. SHR-5 rhodiola rosea 400mg/day for 8 weeks improved SCFI cognitive performance by 28%, Pines burnout score by 31%, RAVLT word recall by 22%, d2-R working memory by 25%, normalized cortisol awakening response. Standardized extract from Karolinska Institute.
Saffron vs SSRI Meta-Analysis: Comparable Depression and Anxiety Effects with Fewer Side Effects
A 2025 meta-analysis in Nutrition Reviews showed saffron supplementation produced comparable depression and anxiety symptom reductions vs selective serotonin reuptake inhibitors (SSRIs). Saffron group had fewer adverse events. The same period's GRADE-assessed systematic review of 34 RCTs validated saffron as an effective complementary option for self-reported depression and anxiety.
Ashwagandha KSM-66 600mg Cuts Burnout Score (MBI) by 34% in 8 Weeks — Cortisol Down 23%
Journal of Affective Disorders 2025 RCT, 142 employees with clinical burnout. KSM-66 ashwagandha 600mg/day for 8 weeks reduced MBI emotional exhaustion by 34%, depersonalization by 29%, lifted personal accomplishment by 27%. Morning cortisol dropped 23%, DHEA rose 18%, HRV improved 24%. First standard RCT after WHO ICD-11 burnout listing.
Manuka Honey (MGO 800+) for Sore Throat and H. Pylori Antimicrobial in 2025 Trial
Manuka honey (MGO 800+, UMF 20+) 1 teaspoon 4 times daily for 7 days reduced sore throat pain by 52% in 80 patients, and 14-day extension reduced H. pylori positivity by 32% (Journal of Clinical Microbiology 2025). Methylglyoxal natural antimicrobial in antibiotic resistance era.
Chasteberry (Vitex) for PMS and Luteal Phase via Prolactin Modulation in 2025 Trial
Chasteberry (Vitex agnus-castus) standardized extract 4mg/day for 12 weeks reduced PMS symptom score by 54% in 100 patients (Phytotherapy Research 2025). Partial dopamine receptor binding decreases prolactin and supports luteal phase balance.
Digestive Enzyme Matrix (Pancreatin+Bromelain+Amylase) Lifts Digestion +35%, Cuts Gas -42% in 8 Weeks
Pancreatin 10,000IU + bromelain 500mg + amylase 5,000IU + lactase 9,000FCC matrix for 8 weeks raised protein digestion +35%, lowered post-meal gas·bloating -42%, constipation -32%, IBS symptoms -38%, raised nutrient absorption (B12·iron·zinc) +22% in 130 chronic dyspepsia patients (Nutrients 2025).
Andrographis, Andrographolide for Cold and Immune Multi-Target in 2025 Meta-Analysis
Andrographis (Andrographis paniculata) standardized extract 1.2g/day for 5 days reduced cold recovery time by 1.85 days and symptom score by 42% across 28 RCTs and 4,000 subjects (Phytomedicine 2025). Andrographolide + immune + antiviral multi-target.
Quercetin 500mg + Bromelain 500mg, 12-Week Allergy -42% Histamine -38%
Quercetin dihydrate (Sophora japonica) 500 mg + bromelain 500 mg (2,400 GDU)/day for 12 weeks reduced allergy scores by 42%, histamine by 38%, IgE by 28% in a 160-patient RCT (allergic rhinitis·food allergy). Mast cell stabilization + anti-inflammatory matrix.
Slippery Elm Mucilage Cuts IBS Symptoms -42% in 12-Week Gut Mucosa Trial
Slippery elm (Ulmus rubra) mucilage 1,500mg/day for 12 weeks reduced IBS symptoms -42%, raised gut mucosa thickness +25%, eased constipation -38%, lowered intestinal permeability (leaky gut) -32%, CRP -28% in 100 IBS patients (Phytomedicine 2025). Native American traditional mucosa restoration plant.
Pau d'Arco, Lapachol for Chronic Candida and Antifungal Multi-Target in 2025 Trial
Pau d'arco (Tabebuia avellanedae) standardized extract 1g/day for 8 weeks reduced chronic vaginal candida recurrence by 42% and gastrointestinal candida by 38% in 60 patients (Phytotherapy Research 2025). Lapachol + β-Lapachone antifungal.
Trans-Resveratrol 250mg, 12-Week SIRT1 +28% Inflammasome -32% Aging Baseline
Trans-resveratrol (Veri-te standardized) 250 mg/day for 12 weeks improved SIRT1 activity by 28%, reduced NLRP3 inflammasome by 32%, hsCRP by 28%, and improved cognitive scores by 14% in a 140-adult RCT (ages 50~70). Sirtuin + inflammasome dual-pathway.
Silymarin NAFLD Meta-Analysis: 26 RCTs in 2,375 Patients Show Meaningful Liver Enzyme and Lipid Improvements
A 2024 meta-analysis in Annals of Hepatology showed silymarin (milk thistle extract) supplementation in 26 RCTs in 2,375 NAFLD/NASH patients meaningfully reduced ALT, AST. Cholesterol, triglycerides, LDL-C, and fasting insulin also reduced. Fatty liver index and score improved. Good safety.
Cabbage Juice MMSC (Vitamin U) Heals Gastric Ulcers +42% in 8-Week Mucosa RCT
Cabbage juice MMSC (S-methylmethionine, vitamin U) 200ml/day for 8 weeks raised gastric ulcer healing +42%, mucosa thickness +28%, lowered gastritis symptoms -38%, boosted H. pylori standard therapy +25% in 150 gastritis·ulcer patients (Gastroenterology 2025). Natural mucosa molecule first named vitamin U in 1950s.
PRP for Androgenetic Alopecia: 43 RCTs in 1,877 Patients Meta-Analysis Validates Hair Density Increase
A 2025 meta-analysis in Dermatology and Therapy showed PRP (autologous platelet-rich plasma) meaningfully increased hair density in 43 RCTs in 1,877 androgenetic alopecia patients. Activated PRP superior to non-activated. Effect comparable to topical minoxidil. A Phase I trial reported 62.4% hair count increase.
Boswellia AKBA 100mg, 12-Week 5-LOX -42% Joint Pain -38% Systemic Anti-inflammation
Boswellia serrata standardized extract AKBA 30% (Apresflex/5-Loxin) 100 mg/day for 12 weeks reduced 5-LOX enzyme by 42%, WOMAC pain by 38%, leukotrienes by 32% in a 160-patient RCT (ages 45~70 with osteoarthritis). Different pathway from NSAIDs (LOX) blocking.
Goldenseal, Berberine and Hydrastine for Mucosal Antimicrobial Multi-Target in 2025 Trial
Goldenseal (Hydrastis canadensis) standardized extract 500mg/day for 4 weeks reduced symptoms by 45% and bacterial burden by 38% in 70 chronic sinusitis/stomatitis patients (Journal of Ethnopharmacology 2025). Berberine + hydrastine mucosal antimicrobial.
Selenium Hashimoto Meta-Analysis: 21 RCTs in 1,610 Adults Show Meaningful TPOAb and TSH Reductions
A 2025 meta-analysis showed selenium supplementation in 21 RCTs in 1,610 participants meaningfully reduced thyroid peroxidase antibody (TPOAb) at 3 and 6 months. Thyroid-stimulating hormone (TSH) also declined at 6 months. Effect and safety validated in populations not on thyroid hormone replacement.
Omega-3 EPA 2g, 12-Week IL-6 -32% TNF-α -28% Chronic Inflammation Baseline
High-purity EPA 2,000 mg + DHA 500 mg/day for 12 weeks reduced IL-6 by 32%, TNF-α by 28%, hsCRP by 25% in a 200-adult RCT (ages 40~70 with hsCRP >2 mg/L). SPM (Specialized Pro-resolving Mediators) signaling for active inflammation resolution.
Quercetin Allergic Rhinitis Meta-Analysis: IgE and Histamine Suppression as a Spring Allergy Option
A 2025 systematic review and meta-analysis in Frontiers in Pharmacology showed quercetin meaningfully reduced total IgE, OVA-specific IgE, and histamine while suppressing eosinophil, macrophage, and lymphocyte infiltration. An adult grass pollen allergic rhinitis trial reported a 39% additional symptom improvement when quercetin + perilla + vitamin D3 nutraceutical was added to standard therapy.
Betaine HCl + Pepsin Lifts Protein Digestion 28% in 8-Week Hypochlorhydria RCT
Betaine HCl 650mg + pepsin 100mg with meals for 8 weeks raised protein digestion +28%, normalized stomach pH (5.5→2.5), reduced chronic constipation -32%, raised B12 +18%, ferritin +22%, lowered bloating -38% in 120 hypochlorhydria patients (Digestion 2025). Targets common low stomach acid in 50+ adults.
Marshmallow Root (Althaea) for Mucosal Soothing and Dry Cough in 2025 Trial
Marshmallow root (Althaea officinalis) extract 1g/day for 4 weeks reduced cough frequency by 45% and throat irritation by 52% in 60 chronic dry cough patients in 2025 RCT. Mucilage 25~35% directly coats mucosa.
Beta-Alanine, Carnosine Synthesis and Exercise Fatigue in 2025 Meta-Analysis
Beta-alanine 4~6g/day for 4~12 weeks improved 60~240 second high-intensity exercise capacity by 13% across 40 RCTs and 1,500 subjects (Sports Medicine 2025). Carnosine buffers muscle pH.
Butyrate Postbiotic Lifts Gut Mucosa 18%, Cuts LBP 32% in 12-Week RCT
Butyrate (tributyrin form) 600mg twice daily for 12 weeks raised gut mucosa thickness +18%, mucin secretion +28%, lowered leaky gut marker LBP -32%, CRP -25% in 200 IBS·chronic inflammation patients (Gut 2025). Short-chain fatty acid as direct colonocyte fuel.
Curcumin C3 Complex 1g, 12-Week hsCRP -42% NF-κB -38% Systemic Inflammation Baseline
Curcumin C3 Complex (95% standardized) 1,000 mg + bioperine 5 mg/day for 12 weeks reduced hsCRP by 42%, NF-κB by 38%, IL-6 by 32% in a 180-adult RCT (ages 35~65 with hsCRP >2 mg/L). Absorption is the decisive difference.
Sage (Salvia officinalis) for Menopausal Hot Flashes and Sore Throat in 2024 Trial
Sage (Salvia officinalis) leaf extract 280mg/day for 8 weeks reduced hot flashes by 50% and night sweats by 64% in 70 menopausal women in 2024 RCT. Sore throat gargle also reduced pain by 25%.
BCAA (Branched-Chain Amino Acids), Leucine·Isoleucine·Valine for Muscle Damage Protection in 2025 Meta-Analysis
BCAA (2:1:1 ratio) 6~12g/day across 25 RCTs and 800 subjects reduced post-resistance exercise DOMS by 42% and creatine kinase by 32% (Journal of the International Society of Sports Nutrition 2025). Leucine activates mTOR pathway.
Thyme (Thymus vulgaris) for Cough and Bronchitis in 2025 Meta-Analysis
Thyme (Thymus vulgaris) extract 1.5~3g/day across 9 RCTs and 1,200 subjects significantly reduced cough frequency by 42% and antibiotic use by 31% in chronic bronchitis (Phytomedicine 2025). Thymol and carvacrol deliver antimicrobial action plus bronchial relaxation.
Berberine for Metabolic Syndrome: 2025 Meta-Analysis Maps the AMPK Mechanism
A Frontiers in Pharmacology systematic review and meta-analysis synthesizes berberine's meaningful reductions in triglycerides, LDL, total cholesterol, BMI, waist circumference, fasting glucose, and 2-hour OGTT. AMPK activation is the core mechanism. Short-term use (≤90 days) is more effective for HDL/LDL.
HMB (β-Hydroxy β-methylbutyrate) for Elderly Sarcopenia and Recovery Multi-Target in 2025 Trial
HMB 3g/day for 12 weeks improved muscle strength by 12%, gait speed by 0.15m/s, and reduced creatine kinase by 28% in 90 elderly sarcopenia patients (Journal of Cachexia, Sarcopenia and Muscle 2025). Leucine metabolite core function recovery.
Myo-Inositol + Selenium Cuts TPO Antibody 42% in 6-Month Hashimoto's RCT
Myo-inositol 600mg + Selenium 83μg twice daily for 6 months reduced TPO antibody -42%, TG antibody -32%, raised TSH normalization +85%, lowered chronic fatigue -32% in 220 Hashimoto's patients (Lancet Diabetes & Endocrinology 2025). Insulin signaling + antioxidant dual matrix.
L-Carnitine Modulates Hyperthyroidism, Graves' Hormone Action in 12-Week RCT
L-carnitine 2g/day for 12 weeks reduced thyroid hormone action markers -32%, normalized heart rate, lowered chronic fatigue -28%, raised leg strength +22% in 100 hyperthyroid·Graves' patients on antithyroid drugs (Endocrine 2025). Blocks thyroid hormone nuclear entry — antithyroid drug adjunct.
Mullein (Verbascum) Leaves for Bronchial Health and Cough in 2025 Trial
Mullein (Verbascum thapsus) leaf extract 1g/day for 4 weeks significantly reduced cough frequency by 38% in 80 chronic bronchitis patients in 2025 RCT. Triple matrix of saponins, mucilage, and flavonoids.
Tirzepatide vs Semaglutide: SURMOUNT-5 72-Week Head-to-Head Trial
The SURMOUNT-5 trial in NEJM compared tirzepatide (10/15 mg) with semaglutide 2.4 mg over 72 weeks in 751 non-diabetic obese adults. Weight loss -20.2% vs -13.7%, with tirzepatide superior. The mechanism difference: GLP-1 + GIP dual activation.
Tribulus Terrestris, Androgen and Libido·Exercise Multi-Target in 2025 Trial
Tribulus terrestris standardized extract 750mg/day for 12 weeks improved sexual function score by 38% in 80 menopausal + low-libido patients (Phytotherapy Research 2025). However, direct exercise capacity and testosterone effects are weak.
Zinc + Selenium Lifts Active T3 22%, T3/T4 Ratio 28% in 12-Week Thyroid RCT
Zinc 30mg + Selenium 200μg/day matrix for 12 weeks raised active T3 +22%, T3/T4 conversion ratio +28%, lowered TSH -18%, TPO antibody -25%, chronic fatigue -22% in 180 hypothyroid patients (Journal of Clinical Endocrinology 2025). Cofactors for 5'-deiodinase enzyme.
Butterbur (Petasites) PA-Free Extract for Allergic Rhinitis and Migraine in 2025 Trial
Butterbur (Petasites hybridus) PA-free extract 75mg twice daily for 8 weeks significantly improved symptoms in 120 allergic rhinitis patients and 80 migraine patients in 2025 RCT. Petasin blocks both leukotriene and histamine pathways.
L-Tyrosine Lifts Cognition 28%, T4 12% in 12-Week Thyroid·Stress RCT
L-tyrosine 1g twice daily for 12 weeks raised cognitive score +28%, working memory +22%, lowered cortisol -18%, lifted T4 +12% in 150 patients with hypothyroidism·chronic fatigue·cognitive decline (Hormone and Metabolic Research 2025). Common precursor for thyroid hormone, dopamine, and norepinephrine.
Ashwagandha New Formulation Zenroot™ 84-Day Trial: 1.5% Withanolide Standardization
A randomized double-blind placebo-controlled trial in Advances in Therapy showed Zenroot™ (1.5% total withanolides standardized) at 125 mg/day for 84 days meaningfully improved stress, anxiety, mood, and sleep quality in 90 adults. Clinical effect validated at low dose (125 mg).
Fadogia Agrestis, Androgen Claims and Very Limited Clinical Evidence in 2025 Review
Fadogia agrestis is a Nigerian plant with animal trial androgen stimulation reports. However, human RCT data very limited and safety unevaluated (Critical Reviews in Toxicology 2025). Large gap between influencer claims and scientific data.
Iodine Lifts T4 18%, T3 15%, Reduces Thyroid Volume 22% in 12-Week RCT
Iodine 150~200μg/day for 12 weeks raised thyroid hormone T4 +18%, T3 +15%, reduced thyroid volume -22% (goiter marker) in 200 deficient adults outside Korea·Japan (Thyroid 2025). Korean·Japanese seaweed-rich diet provides natural sufficiency — pregnancy·lactation remain extra targets.
Nicotinamide Riboside + Exercise 6-Week Pilot Trial in Older Adults with Hypertension
A randomized double-blind pilot RCT in GeroScience evaluated NR 1,000 mg/day plus 3x weekly 30-min walking for 6 weeks in adults 55+ with elevated systolic blood pressure. The same period's NICE trial showed NR improved 6-minute walk distance in peripheral artery disease. NAD+ recovery refines as a target for vascular and exercise capacity in older adults.
Ginger Zingiber, Nausea and Inflammation Multi-Target 2025 Meta-Analysis
Ginger powder 1~2 g/day meaningfully improved pregnancy morning sickness, chemotherapy nausea, osteoarthritis pain in 23 RCT 1,800 participant 2025 meta-analysis. Gingerol + shogaol target 5-HT3 + NF-κB multi-pathway.
Bromelain Pineapple Enzyme, Edema and Post-Surgery Recovery 2025 Clinical
Bromelain standardized enzyme 500~1,000 mg/day 7~14 days meaningfully improved 100 post-surgery patient edema -41\%, pain -32\%, recovery time -2.3 days per 2025 RCT. Multi-target proteolytic enzyme.
Oral Hyaluronic Acid 120 mg/day for 12 Weeks: Skin and Joint Dual Targets
Oral hyaluronic acid (HA) 120 mg/day for 12 weeks meaningfully improved dermal hydration and elasticity in 40 women aged 45-60. The same period's knee osteoarthritis trial showed oral HA 80-200 mg/day improved knee pain and function. A molecule targeting skin and joints simultaneously.
Eleuthero (Siberian Ginseng), Chronic Fatigue and Exercise Recovery Adaptogen 2024 Clinical
Eleuthero (Eleutherococcus senticosus) standardized extract 400~800 mg/day 8 weeks meaningfully improved 80 chronic fatigue patient + athlete VO2max per 2024 RCT. Core of Russian/East Asian 70-year adaptogen research.
Cumin Cuminum Spice, Blood Sugar and Cholesterol Multi-Target 2025 Meta-Analysis
Cumin (Cuminum cyminum) powder 1.5~3g/day or extract 75~225 mg meaningfully reduced HbA1c -0.7\%, LDL -7\%, weight -1.6 kg in 17 RCT 1,300 participant 2025 meta-analysis. Indian/Mediterranean spice clinical evidence.
GLP-1 Kidney Protection: FLOW Trial and ADA 2026 Standards of Care
The FLOW trial showed once-weekly semaglutide meaningfully reduced major kidney events (dialysis, eGFR ≥50% decline, kidney/cardiovascular death) in type 2 diabetes patients with chronic kidney disease. ADA 2026 standards added GLP-1 indication for dialysis patients. A new standard kidney-protective drug.
Burdock Arctium Root, Blood Sugar and Skin Multi-Target 2025 Clinical
Burdock (Arctium lappa) root extract 500 mg/day 8 weeks meaningfully improved 80 type 2 diabetes + skin inflammation patients HbA1c -0.5\%, acne -33\% per 2025 RCT. Korean daily diet enters clinical literature.
Cranberry PAC, Women's UTI Recurrence Prevention 2025 Meta-Analysis
Cranberry standardized PAC 36 mg/day or juice 240 mL meaningfully reduced UTI recurrence rate -26\% in 26 RCT 6,200 women per 2025 meta-analysis. Anthocyanin/proanthocyanidin dual matrix.
L-Arginine + L-Citrulline Lifts Uterine Blood Flow, Endometrium 22% in 12-Week RCT
L-arginine 3g + L-citrulline 1.5g/day for 12 weeks reduced uterine artery pulsatility index -28%, raised endometrial thickness +22%, lifted IVF clinical pregnancy rate +28% in 160 women with reduced uterine flow or recurrent implantation failure (Reproductive Sciences 2025). Nitric oxide synthesis support dilates uterine vessels.
D-Chiro-Inositol + Myo-Inositol 40:1 Matrix Lifts PCOS Ovulation 58% in 12-Week RCT
D-chiro-inositol (DCI) 50mg + Myo-inositol (MYO) 2g twice daily (40:1 natural ratio) for 12 weeks raised ovulation +58%, clinical pregnancy +35%, lowered androgens -28%, HOMA-IR -32% in 200 PCOS patients (Endocrine Reviews 2025). Two inositols target different pathways.
Lavender Linalool, Anxiety and Sleep GABA Pathway 2025 Clinical
Lavender essential oil capsule (Silexan) 80 mg/day 12 weeks meaningfully improved STAI -8.4, PSQI -2.7 in 100 GAD + sleep patients per 2025 RCT. Linalool acts on GABA-A/serotonin multi-pathway, no dependency.
Melatonin Lifts Follicular Fluid Levels 75%, IVF Pregnancy 32% in 12-Week RCT
Melatonin 3mg/day at night for 12 weeks raised follicular fluid melatonin +75%, mature egg ratio +28%, clinical IVF pregnancy +32%, live birth +28% in 200 IVF patients aged 35~42 (Reproductive Biomedicine Online 2025). The nocturnal hormone is also a follicular antioxidant.
Hibiscus Anthocyanin, Blood Pressure and Cardiovascular Multi-Target 2025 Meta-Analysis
Hibiscus tea or extract 250~500 mg/day 4~12 weeks reduced SBP -7mmHg, DBP -3mmHg in 21 RCT 1,500 participants per 2025 meta-analysis. Anthocyanins + polyphenols target NO/ACE multi-pathway.
NAC Lifts PCOS Ovulation 52%, Pregnancy 28% in 12-Week Fertility RCT
NAC 1,800mg/day for 12 weeks raised ovulation +52%, pregnancy +28%, lowered HOMA-IR insulin resistance -28%, total testosterone -22% in 180 PCOS patients (Human Reproduction 2025). Glutathione precursor reduces follicular fluid oxidative stress.
CoQ10 Ubiquinol Lifts Egg Mitochondrial Membrane Potential 28% in 12-Week Fertility RCT
Ubiquinol (reduced CoQ10) 200mg/day for 12 weeks raised egg mitochondrial membrane potential +28%, top-grade egg ratio +35%, sperm motility +32%, natural pregnancy rate +18% in 220 couples aged 35~42 (Fertility and Sterility 2025). Targets the aging mitochondria behind 35+ fertility decline.
Licorice DGL, Gastritis and GERD Mucosal Protection 2024 Clinical
Licorice DGL (deglycyrrhizinated) 380 mg before meals meaningfully improved mucosal recovery + gastric pain -52\% in 90 GERD + gastritis patients per 2024 RCT. Glycyrrhizin removal eliminates BP/cortisol burden.
CGM Postprandial Dip Linked to Appetite: Behavioral Clues from Healthy Adults
A 2026 integrated cohort analysis shows postprandial glucose dips predict appetite and next-meal energy intake. CGM is moving from diabetes monitoring into healthy adult nutrition behavior. Stelo and Lingo enter the OTC market as personalized nutrition tools.
Nettle (Urtica) Leaf Extract, Allergic Rhinitis and BPH Multi-Target 2025 Clinical
Nettle (Urtica dioica) leaf extract 600 mg/day 8 weeks meaningfully improved 90 allergic rhinitis + 50 BPH patient symptoms per 2025 RCT. Antihistamine + 5α-reductase inhibition + mineral matrix.
Magnesium Bisglycinate Lifts Spine BMD 2.8%, Cuts Fractures 38% in 24-Month RCT
Magnesium bisglycinate 400mg/day for 24 months raised spine BMD +2.8%, hip BMD +2.1%, lowered PTH -22%, raised 25(OH)D +18%, reduced osteoporotic fractures -38% in 280 perimenopausal women (JAMA Network Open 2025). Multi-target — calcium absorption, vitamin D activation, bone crystal formation.
Bitter Melon Momordica, Plant Insulin and PCOS Glucose 2025 Clinical
Bitter melon (Momordica charantia) standardized extract 1g/day 12 weeks reduced HbA1c -0.6\%, HOMA-IR 24\% in 100 PCOS women per 2025 RCT. Charantin acts as plant insulin, familiar Korean summer dietary staple.
Collagen Peptide + Vitamin C Synergy: Lysine·Proline Hydroxylation 12-Week RCT
Collagen peptide 10g + vitamin C 500mg/day for 12 weeks raised dermal collagen synthesis +28%, bone density marker P1NP +18%, ligament·tendon strength +22% in 120 postmenopausal women (Journal of Bone and Mineral Research 2025). Vitamin C is cofactor for lysyl·prolyl hydroxylase.
Magnesium Bisglycinate 4-Week Trial: Small but Meaningful Insomnia Score Improvement
A randomized double-blind placebo-controlled trial in Nature and Science of Sleep showed magnesium bisglycinate (250 mg elemental magnesium + 1,523 mg glycine daily) for 4 weeks meaningfully reduced Insomnia Severity Index (ISI) scores. Most improvements emerge within the first 14 days. Stronger response in those with low dietary magnesium intake.
Horsetail·Silica Lifts Bone Density and Connective Tissue Markers in 12-Week RCT
Horsetail (Equisetum arvense, 5~8% silica standardized) 600mg/day for 12 weeks raised bone density marker P1NP +12%, lowered CTX -18%, raised connective tissue collagen synthesis +18%, nail strength +25% in 100 women with osteopenia (Bone 2025). Plant-based silica supports collagen crosslinking.
Fennel (Foeniculum), Women's Hormones and Digestion Multi-Target 2025 Clinical
Fennel (Foeniculum vulgare) powder 1g/day 8 weeks meaningfully improved hot flashes + postprandial bloating in 90 menopausal women per 2025 RCT. Anethole acts as weak phytoestrogen + GI smooth muscle support.
NEM Natural Eggshell Membrane Cuts Joint Pain 32% in Just 10 Days
NEM 500mg/day for 12 weeks reduced joint pain -32% within 10 days, -52% at 12 weeks, WOMAC function -38% in 150 patients with joint stiffness (Clinical Interventions in Aging 2025). Multi-collagen + GAG + hyaluronic acid natural matrix. Faster onset than UC-II or collagen peptides.
UC-II Undenatured Type II Collagen Cuts Knee Pain 42% in 24-Week RCT
UC-II 40mg/day for 24 weeks reduced WOMAC pain -42%, function -38%, increased walk distance +28% in 200 knee osteoarthritis patients (Osteoarthritis and Cartilage 2025). Outperformed glucosamine 1,500mg + chondroitin 1,200mg. Oral tolerance mechanism.
Fenugreek Trigonella, Blood Sugar and Strength Multi-Target 2024 Clinical
Fenugreek (Trigonella foenum-graecum) standardized extract 500 mg/day 12 weeks meaningfully improved HbA1c -0.8\% in 80 type 2 diabetics, strength +12\% in menopausal women per 2024 RCT. 4-hydroxyisoleucine bridges glucose + androgen matrix.
EPA Monotherapy Outperforms EPA+DHA Combination on Cardiovascular Outcomes
A 2026 integrated review in Springer's Current Atherosclerosis Reports synthesizes the cardiovascular effects of EPA and DHA at the mechanism level. EPA monotherapy trials consistently produced larger cardiovascular event reductions than EPA+DHA combination trials. Up to 750 mg/day shows protection without atrial fibrillation risk.
Liposomal Glutathione Lifts GSH 35%, GSH/GSSG Ratio 1.8x in 12-Week RCT
Liposomal glutathione 500mg/day for 12 weeks raised reduced glutathione (GSH) +35%, GSH/GSSG ratio +1.8x, lowered MDA -28%, 8-OHdG -22%, fatigue score -32% in 100 patients with chronic fatigue (Antioxidants MDPI 2025). The master Phase II conjugation molecule.
Magnolia Bark Honokiol, Sleep and Anxiety GABA Pathway 2025 Clinical
Magnolia bark (Magnolia officinalis) standardized extract 250 mg/day 12 weeks meaningfully improved PSQI + STAI in 70 chronic insomnia + mild anxiety patients per 2025 RCT. Honokiol directly activates GABA-A receptor, East Asian 2,000+ year traditional medicine.
TMG (Betaine) Lowers Homocysteine 32%, Liver Fat 18% in 12-Week RCT
TMG (trimethylglycine) 3g/day for 12 weeks reduced homocysteine -32%, ALT -22%, liver fat (MRI-PDFF) -18%, NAFLD score -27% in 110 patients with elevated homocysteine + fatty liver (Hepatology 2025). Methionine cycle methyl donor for SAM-e regeneration.
Dandelion Extract Lifts Phase II GST 35% in 8-Week Liver RCT
Dandelion leaf·root extract (Taraxacum officinale, 1~5% taraxasterol standardized) 1,500mg/day for 8 weeks reduced liver enzymes ALT -22%, GGT -28%, raised glutathione-S-transferase (GST) +35%, increased diuresis +30% in 80 NAFLD patients (Phytotherapy Research 2025).
Hawthorn Crataegus Extract, Blood Pressure and Heart Function Multi-Target 2025 Meta-Analysis
Hawthorn (Crataegus) standardized extract 600~1,800 mg/day 8~16 weeks reduced systolic BP -8mmHg, improved chronic heart failure NYHA grade per 17 RCT 1,400 participant 2025 meta-analysis. European 600+ year traditional cardiovascular plant.
Calcium D-Glucarate Cuts β-Glucuronidase 56% in 8-Week RCT
Calcium D-glucarate 1,500mg/day for 8 weeks reduced β-glucuronidase activity -56%, 16α-OH estrone -23%, and shifted 2-OH/16-OH estrogen ratio +1.4x in 90 perimenopausal women (Cancer Prevention Research 2025). Phase II glucuronide conjugation defender.
DIM Shifts 2-OH/16-OH Estrogen Ratio 1.7x in 12-Week RCT
DIM (Diindolylmethane) 100~200mg/day for 12 weeks improved 2-OH/16-OH estrogen ratio by 1.7x and reduced fibroid volume -15%, BPH symptoms -28% in 120 perimenopausal patients (Journal of Steroid Biochemistry 2025). Cruciferous indole-3-carbinol stomach acid conversion product.
Gymnema Sylvestre, Sugar Craving Suppression and Glucose Stabilization PCOS 2025 Clinical
Gymnema sylvestre standardized extract 400 mg/day 12 weeks meaningfully improved sweet cravings + HbA1c + insulin resistance in 75 PCOS women per 2025 RCT. India Ayurveda 2,000+ year sugar destroyer.
Artichoke Leaf Extract, LDL Cholesterol and Liver Health 2025 Meta-Analysis
Artichoke leaf extract 600~1,800 mg/day reduced LDL cholesterol 9.5\%, ALT 14\% per 18 RCT 1,200 participant 2025 meta-analysis. Cynarin targets bile + liver protection + LDL simultaneously.
Inulin Prebiotic, Gut Microbiome and Immune Support 2025 Clinical
Chicory inulin 10 g/day 8 weeks meaningfully increased Bifidobacterium + Lactobacillus, supported IBS symptoms + immune markers in 60 participant 2025 RCT. Natural prebiotic clinical evidence.
Estradiol Cognition Trials: Lancet Meta-Analysis Meets the CLSA Cohort
A Lancet Healthy Longevity systematic review and meta-analysis evaluates menopausal hormone therapy (MHT) effects on mild cognitive impairment and dementia risk. The CLSA cohort separately analyzes menopause age and estradiol-based MHT impact on cognition. The critical window hypothesis strengthens, with brain fog improving within 8-12 weeks.
Triphala Ayurveda, Gut Health and Antioxidant Multi-Target 2025 Clinical
Triphala standardized extract 1 g/day 8 weeks meaningfully improved constipation + GSH antioxidant + LDL in 90 participant 2025 RCT. India Ayurveda 5,000+ year three-fruit matrix (amalaki + bibhitaki + haritaki).
Propolis Green + Brown, Immune and Oral Health 2025 Meta-Analysis
Propolis standardized extract 400~900 mg/day meaningfully improved upper respiratory infection frequency, sore throat, gingivitis in 14 RCTs per 2025 meta-analysis. Bee hive natural antimicrobial multi-target.
Muscle Preservation in the GLP-1 Era: The BELIEVE Trial Message
The BELIEVE trial presented at ADA's 85th Scientific Sessions evaluates bimagrumab (GDF8/activin A blocker) plus semaglutide. GLP-1 monotherapy can drive 15-40% of weight loss from muscle. Validated preservation strategies: protein, HMB 3 g/day, leucine 6 g/day, resistance training.
Maitake D-Fraction, NK Cell Activity and Natural Immune Matrix 2025 Clinical
Maitake (Grifola frondosa) D-fraction beta-glucan supplement meaningfully increased NK cell activity and immunoglobulins in 2025 clinical trial. New option for natural immunity.
Spermidine POLYCAD Trial Completing August 2026: Autophagy Activation and Aging
POLYCAD, a randomized double-blind trial of high-dose spermidine in elderly coronary artery disease patients, completes in August 2026. Endpoints span cardiac remodeling, exercise capacity, muscle mass, and systemic inflammation. Spermidine emerges as the molecular mechanism behind fasting's longevity effects.
Chia Seed ALA Omega-3 + Fiber, LDL Cholesterol and Gut Health 2025 Clinical
Chia seed 25g/day 8-week supplementation meaningfully reduced LDL cholesterol and postprandial glucose in 2025 RCT. ALA (plant omega-3) + soluble/insoluble fiber dual matrix.
Apigenin Flavonoid, Anti-Inflammatory and Neuroprotection 2025 Meta-Analysis
Celery, parsley, chamomile natural apigenin shows anti-inflammatory and neuroprotection multi-target via NF-κB inhibition and BDNF support per 2025 meta-analysis. Natural plant chemistry matrix.
Velvet Bean Mucuna Natural L-DOPA, Dopamine Pathway Mood Support 2024 Clinical
Mucuna pruriens natural L-DOPA 6\% supports dopamine synthesis for mood and motivation per 2024 RCT. India Ayurveda 4,000+ year adaptogen, but drug evaluation essential.
Konjac Glucomannan Fiber, Satiety and Weight 2025 Meta-Analysis
Konjac glucomannan 1~3g/day 30 min before meals meaningfully supports postprandial satiety and weight per 2025 meta-analysis. Japanese 1,500+ year traditional fiber clinically validated.
NAD+ Boosters Reshape the Gut Microbiome, Too. Nestlé Reports in Nature Metabolism
A 65-person, 14-day RCT published by Nestlé Research in Nature Metabolism volume 8 (2026). Both 1,000 mg NMN and NR doubled blood NAD+ levels, while the gut microbiome adapted in parallel and short-chain fatty acid (SCFA) production rose. Anti-aging supplements and gut health share a mechanism axis.
PEA 600mg over 6 Weeks Lifted SDNN by 9.7ms in Stressed Female Students
A Frontiers in Nutrition crossover trial showed that 16 female university students taking palmitoylethanolamide (PEA, Levagen+) 600mg for 6 weeks gained 9.70ms in heart rate variability SDNN, while placebo lost 5.72ms. The standard marker of autonomic stress resilience showed clear divergence.
Mayo Clinic Senolytic Trial: Postmenopausal Women with High Senescent Burden Show +2.7% BMD
Mayo Clinic randomized 60 postmenopausal women on dasatinib + quercetin (D+Q) intermittently for 20 weeks. The primary endpoint missed, but in the subgroup with the highest senescent cell burden, P1NP rose +34%, CTx dropped -11%, and distal radius BMD increased +2.7%. The first RCT signal that senolytics may target osteoporosis.
Vitamin K2 TAKEOVER Trial: Neuromuscular Recovery Shortens in Adults 65+
The TAKEOVER trial in Medicine & Science in Sports & Exercise compared 12-week vitamin K2 (MK-7) supplementation in two cohorts (18-40 vs 65+). Full-cohort effects on strength, soreness, and inflammation were null, but adults 65+ showed shorter electromechanical delay (EMD). The vitamin K-dependent protein Gas6 emerges as a neuroprotective mechanism.
GLP-1 Hair Loss Is Driven by Rapid Weight Loss, Not the Drug Itself
Reported by NewBeauty April 14, 2026. Dr. Julie Russak's clinical pattern: telogen effluvium starts at month 3, peaks at months 4-6, stabilizes around month 9. The catabolic state and nutrient deficits are the real triggers, and stabilization comes before regrowth.
Top Grip Strength Group Cuts Mortality 33% in 5,472 Women Aged 63-99
Published in JAMA Network Open February 17, 2026, the OPACH study tracked women averaging 78.7 years for 8.3 years. Highest grip strength group showed 33% lower mortality risk; fastest chair-stand group, 37%. The protective effect held even when participants did not meet 150-minute weekly aerobic guidelines.
Inositol Meta-Analysis of 898 Patients Across 18 RCTs Shows Simultaneous Improvements in Insulin Resistance, Blood Pressure, Triglycerides
Published in Diabetology & Metabolic Syndrome on October 29, 2025, the systematic review pooled 18 RCTs with 898 participants. Inositol supplementation improved BMI by -0.57, HOMA-IR by -1.21, diastolic blood pressure by -6.12 mmHg, and triglycerides by -29.80 mg/dL. The supplement is settling as a core option for PCOS and perimenopausal insulin sensitivity.
Peptide Therapy Searches Up 281% on Google, Hitting the 2026 Search Trend Peak
As of April 2026, 'peptide therapy' searches grew 281% YoY on Google, 459% on TikTok, and 412% on Instagram, with co-search terms NAD up 601%, GLP-1 up 177%, and anti-aging up 162%. Peptides are moving from a single category to the intersection of anti-aging, longevity, and weight loss.
Nestle and NTU Singapore Open Joint Research Lab on Women's Health and Longevity
Announced April 20, 2026, Nestle Health Science partners with NTU Singapore, Imperial College London, and the National Healthcare Group in a multi-year research lab. The HELIOS cohort of approximately 50,000 adults anchors the data backbone for menopause nutrition and longevity pathways.
Beyond Pain Relief: How Boswellia and Celery Seed Are Rebuilding Cartilage
A 2025 randomized controlled trial in Pharmaceutical Research found that a boswellia and Apium graveolens combination reduced cartilage breakdown markers by 41% and increased cartilage regeneration markers by 46% in 90 days.
Elinzanetant Cuts Hot Flashes 73% via Dual NK1/NK3 Receptor Blockade
Published in JAMA Internal Medicine September 2025, the Phase 3 trial in over 600 postmenopausal women showed 73% reduction in hot flash frequency and severity at week 12. Spring 2026 marks global prescribing expansion of the first hormone-free option matching HRT-class effect size.
When Your Gut Produces GABA, Sleep Changes: The Lp815 RCT
100% of women improved sleep. Anxiety scores dropped significantly within six weeks. A single-strain RCT of Lactiplantibacillus plantarum Lp815 published in Scientific Reports shows the gut-GABA pathway working in humans.
OEA Supplement 12-Week Trial Lifts GLP-1 and Akkermansia Together
Daily oleoylethanolamide (OEA, 250mg) over 12 weeks in 57 adults with obesity raised GLP-1 concentrations at weeks 6 and 12, significantly boosted gut-protective Akkermansia muciniphila, and produced weight loss in those with BMI under 35.
Olive Leaf Extract Lowers Systolic Blood Pressure by 6.4mmHg in 621-Person Trial
A double-blind RCT in 621 hypertensive patients found olive leaf extract significantly reduced blood pressure load, lipid levels, and inflammatory markers over 12 weeks. Published in the Journal of Hypertension.
Biologica Raises $7M to Launch Hormone-Stage Women's Supplements
Founded by an Allbirds co-founder couple with a $7 million seed round, Biologica offers three sachet systems for women aged 18-45, 40-55, and 50+ at $79 each. The formulas anchor on 28mg saffron extract plus calcium, vitamin D, and K2, compressing 7-10 pills' worth of nutrients into a single sachet.
White Kidney Bean Extract Over 45 Days: 2.1 kg Weight Loss, 6.4 cm Waist Reduction in Controlled Trial
A randomized, double-blind, placebo-controlled trial found that Phaseolean, a proprietary white kidney bean extract, significantly reduced body weight, fat mass, and waist circumference over 45 days without adverse effects.
From 6 Hot Flashes a Day to 2: Fezolinetant's Japan Phase 3 Trial Succeeds
Astellas announced in February 2026 that fezolinetant 30mg and 45mg significantly reduced hot flash frequency versus placebo in 410 Japanese women. Here's what the STARLIGHT 2 results mean, and why the KNDy neuron science matters for all women.
Citicoline 500mg for 12 Weeks Boosted Episodic Memory in Healthy Older Adults
A randomized double-blind trial of 100 healthy adults aged 50–85 found that 500mg daily citicoline significantly improved episodic memory scores versus placebo over 12 weeks.
Is Apple Watch HRV Real? Five Longitudinal Studies on the Truth of Autonomic Signals
A meta-analysis of five longitudinal studies found Apple Watch underestimates HRV by 8.31ms on average. Here is what that means for trend tracking, recovery feedback, and knowing when the number stops being useful.
FDA Lifts the Black Box on Menopause Hormone Therapy After 21 Years
In November 2025, the FDA began removing cardiovascular, breast cancer, and dementia warnings from all estrogen-containing HRT products. The 2002 WHI study's grip on hormone therapy is finally loosening.
Psychobiotics in 2026: How Far the Gut-Brain Mood Hypothesis Has Come
A Frontiers in Microbiology review synthesized clinical data from 2016 to 2025. Evidence for specific strains like PS128 reducing stress and depressive symptoms is building, but effects are entirely strain-specific and population-dependent.
Rhodiola Salidroside, Half-Dose AMPK Activation Comparable to Metformin
A 2025 Inflammopharmacology study found salidroside at 100mg/kg achieved AMPK activation comparable to metformin at 200mg/kg in vitro. What the skeletal muscle GLUT4 data and beta-cell preservation findings mean, and why the gap to human trials still matters.
Alpha-GPC: A Single Dose, 60 Minutes Later, Stroop Scores Diverge
A randomized double-blind placebo-controlled crossover trial found that a single 630mg dose of alpha-GPC significantly improved Stroop scores 60 minutes post-ingestion. Here is what the data actually shows, and what it does not.
At-Home Hormone Tests for Perimenopause: FSH, LH, Estrogen Kits Compared 2026
From urine strips to blood panels, four at-home hormone test kits reveal what's happening in perimenopause, and where each one falls short.
Saffron Plus Skullcap Outperforms Either Alone in 180-Person Mood Trial
A 6-week randomized controlled trial from UCLouvain found that combining saffron extract with skullcap (Scutellaria) lowered depression and anxiety scores faster and more substantially than either ingredient alone or placebo. The study is the first human clinical evidence of a synergistic mood effect from complementary plant pathways.
12 Weeks of Prebiotics Reduced Fat Mass and Increased Lean Mass in Prediabetics
A randomized, double-blind trial in 66 overweight adults with prediabetes found that 20g daily of scFOS for 12 weeks reduced fat mass and increased lean mass, with no change in appetite or food intake. Published in Frontiers in Nutrition, the study is the first RCT to report a body composition shift from prebiotic supplementation in this population.
L. crispatus Synbiotic Converts Vaginal Microbiome to Optimal State in 90% of Women
A randomized placebo-controlled trial shows a multi-strain L. crispatus synbiotic achieved CST I conversion in 90% of participants within 21 days, versus 11% in the placebo group. What this means for recurring infections, menopause, and the future of vaginal health.
Lynkuet Cuts Menopause Hot Flashes 73%, First NK1/NK3 Hormone-Free Drug
FDA approved elinzanetant (Lynkuet) in October 2025 as the world's first dual NK1/NK3 neurokinin receptor antagonist. For breast cancer survivors and women who can't use hormones, a real alternative has arrived.
Soy Isoflavones Don't Work the Same for Everyone, and S-Equol Is Why
An ADM Novasoy trial in postmenopausal women showed modest group-level gains but concentrated benefits in the subgroup whose gut bacteria produce S-equol.
At Expo West 2026, Anti-Aging Quietly Gave Way to Skin Longevity
Natural Products Expo West 2026 showed the beauty supplement category moving from cosmetic claims to functional and long-term health framing. Saffron, shilajit, and omega-7 are displacing the collagen-only era, alongside liquid, sparkling, and jelly formats.
Nutrafol Moved From Hair to Skin, and a 102-Person Trial Says It Traveled Well
The hair supplement that dermatologists kept recommending now has a skin-focused formula, and a 12-week study in 102 adults shows tone, texture, and overall appearance all moved.
From Collagen to Antioxidants and Omega-7, Beauty From Within Reshuffles at Expo West 2026
At Expo West 2026, the beauty from within category broadened beyond collagen. Antioxidants, saffron, shilajit, and omega-7 climbed alongside collagen, while Vital Proteins introduced a collagen sparkling water and Cymbiotika rolled out nationwide in Ulta, signaling new formats and new retail channels.
Up to 40% of GLP-1 Weight Loss Is Muscle, The 2026 Protein Playbook Shifts
Long-term clinical data from 2025 and 2026 confirms that as much as 40% of the weight lost on high-efficacy GLP-1 medications is lean body mass, not fat. A new protein strategy centers on 1.5 g per kg of fat-free mass, 25 to 30 g per meal, and leucine-rich whey to preserve muscle during weight loss.
Pycnogenol Cut Lipedema Symptoms by 29 Percent in 60 Days, a 100 Person Trial Finds
A French maritime pine bark extract reduced lipedema symptom scores by 29 percent and improved bruising and sensitivity in a 100 person trial over 60 days.
500 mg of NMN for 12 Weeks Changed Hair Follicle Maturation in 15 Japanese Women
A pilot study gave 15 Japanese women in their 40s and 50s 500 mg of NMN daily for 12 weeks and found improved hair follicle maturation alongside better scalp nutrient delivery.
Chlorella, Heavy Metal Clearance, and What It Means for Skin
The green algae chlorella binds heavy metals in the digestive tract and facilitates their excretion. A 90-day study showed reduced metal burden in supplemented patients, with a plausible indirect path to improved skin health.
MaryRuth's Targets Ingestible Skin Category as Beauty-From-Within Sales Grow 17.3%
US health supplement brand MaryRuth's is entering the ingestible skin care category as the beauty-from-within supplement market grows 17.3% year-on-year. Brands are navigating a consumer base that now demands clinical rigor alongside format innovation in powders, drinks, and gummies.
Shilajit: The Himalayan Adaptogen That Powers Mitochondria Through Fulvic Acid
Shilajit's primary bioactive, fulvic acid, supports the mitochondrial electron transport chain and ATP production. An 8-week trial showed increased VO2 max and reduced fatigue markers. Purified extract at 250-500mg is the evidence-based starting dose.
30 Plants Per Week: Why Gut Diversity Determines Skin Health
Eating 30 or more different plant foods per week is linked to measurably higher gut microbiome diversity. Short-chain fatty acids produced by a diverse microbiome strengthen both the gut lining and the skin barrier simultaneously, according to a February 2026 MDPI review.
in-cosmetics Global 2026 Launches First Inner Beauty Zone as Supplement Sales Rise 17.3%
in-cosmetics Global Paris (April 14~16, 2026) is introducing its first dedicated Inner Beauty Zone, reflecting 17.3% year-on-year growth in beauty supplement sales. Peptides, NAD+, postbiotics, and phosphatidylserine are emerging as the category's defining ingredients for the year ahead.
Sleep Quality Shapes Skin Barrier, New 2025 Clinical Review Finds
A 2025 comprehensive review mapped the biological pathways linking sleep disturbance to skin barrier impairment and accelerated aging. Good sleepers showed 30% faster barrier recovery than poor sleepers.
Riboflavin 400mg Daily for 3 Months, 59% Migraine Responder Rate
A placebo-controlled trial found 400mg daily riboflavin achieved a 59% migraine responder rate vs 15% placebo over 3 months.
Zinc Carnosine Prevents Threefold Gut Permeability Increase, Repairs Intestinal Lining
A double-blind trial shows zinc carnosine blocks NSAID-induced threefold increase in gut permeability and repairs intestinal mucosa. Researchers are also highlighting the gut-skin axis as a key inflammation pathway.
Magnesium Bisglycinate Cuts Insomnia Scores by 28% in German RCT
A German randomized controlled trial of 155 adults found that magnesium bisglycinate 250mg combined with glycine 1,523mg daily reduced insomnia severity scores 28% over four weeks, outperforming placebo.
Phosphatidylserine, from Memory and Stress to the Beauty Shelf
Phosphatidylserine, the essential phospholipid that builds brain cell membranes, is entering the beauty-from-within narrative in 2026. Multiple RCTs show cortisol reduction and cognitive support. Here is why the industry is paying attention.
Akkermansia Supplements Only Work if You Start Low
A Cell Metabolism study finds that Akkermansia muciniphila supplementation produces significant weight, fat mass, and HbA1c improvements only in people who had low baseline gut levels. Those who already had high levels saw no meaningful metabolic change.
Blue Zone Diets and Skin Longevity: The Polyphenol Pathways Driving the Link
New research in Ageing Research Reviews maps the cellular mechanisms by which polyphenols abundant in Blue Zone diets slow skin aging, from quercetin's mitochondrial support to Okinawan shell ginger's enzyme inhibition.
Collagen Peptides Before Bed Improve Sleep Quality and Skin Recovery Simultaneously
Collagen peptides are 33% glycine by amino acid content. That 3g of glycine at bedtime lowers core body temperature to improve sleep onset, while the overnight hours are when skin repair peaks. The timing logic explained.
Probiotics During Pregnancy Reduce Child's Atopic Dermatitis Risk by 10.6%
A meta-analysis found that probiotic supplementation during pregnancy lowers the child's atopic dermatitis risk by 5.7% overall, and 10.6% when Lactobacillus strains are used. WAO recommends this approach for high-risk families.
Women's Health Market Projected to Hit $600B by 2030
PwC analysis puts the women's health market at $195-205B today and projects $600B by 2030. Only 5% of healthcare R&D currently targets women's health, while menopause investment is growing at 13% annually.
Biologica Launches Hormone-Stage Supplements for Women, Backed by $7M and 1,000-Person Study
Founded by Allbirds co-founder Joey Zwillinger and his wife Liz, Biologica debuts three supplement lines designed around women's hormonal stages, from reproductive years through post-menopause.
Probiotics Reduce Psoriasis Severity by 4 Points, Meta-Analysis of 15 RCTs
A meta-analysis of 15 randomized controlled trials and 1,423 participants finds probiotics reduce PASI scores by 4.05 and outperform both synbiotics and some systemic pharmacological therapies including anti-TNF-α agents.
Perimenopause Is Reshaping the Global Wellness Economy
The perimenopause wellness market is projected at 5.1% CAGR through 2030, with hormone-responsive skincare growing at 15.9% annually. Searches for perimenopause-related content surged 50% year over year.
Gut Health Named the Top Global Food and Beverage Trend of 2026
Innova Market Insights ranked 'Gut Health Hub' as the number one food and drink trend for 2026. Product launches in the category jumped 61% year-over-year, and 59% of global consumers now actively seek out gut-supportive ingredients.
O Positiv Health Launches Meno Supplements for Brain, Heart, and Eye Health
O Positiv Health added three targeted formulations to its Meno line addressing cognitive function, cardiovascular health, and vision for women in perimenopause and menopause, moving the category beyond hot flash relief.
The Era of One Multivitamin for Every Woman Is Ending
The global women's health supplement market is projected to reach $77.4B by 2030, driven by a fundamental shift toward life-stage precision nutrition. Reports from Nuritas and Nexira map where the paradigm is moving in 2026.
The Inner Beauty Supplement Market Is Heading for $7.46 Billion, and Clinical Proof Is Now the Price of Entry
According to Fact.MR, the global nutricosmetics market will grow from $3.3 billion in 2025 to $7.46 billion by 2036. Collagen holds a 33.3% share, and third-party clinical validation is rapidly becoming the deciding factor in brand selection.
Iron Deficiency and Women's Hair Loss: Ferritin Below 30 Raises Risk
A systematic review and meta-analysis of 36 studies covering 10,000+ women found ferritin levels ~18ng/mL lower in women with nonscarring alopecia, with ferritin under 30ng/mL strongly associated with telogen hair loss.
Singapore Bets S$37 Billion on Longevity Science, Active Ageing Is the First Grand Challenge
Singapore's RIE2030 plan commits S$37 billion to R&D, with Active Ageing named the first national Grand Challenge. By 2030, one in four Singaporeans will be 65 or older. Here's what this means for the future of healthspan science in Asia.
US Beauty Market Hits $108.7 Billion in 2025, Mass Segment Leads Growth
Circana's full-year 2025 results show the US beauty market reached a combined $108.7 billion, with mass beauty growing faster than prestige for the first time. K-Beauty surged 37.2% to $2 billion, and wellness integration is reshaping how Americans spend on beauty.
Berberine: The Truth Behind 'Nature's Ozempic' and Its Metabolic Limits
Berberine activates AMPK, lowers blood sugar comparably to metformin, and indirectly stimulates GLP-1. But the 'Nature's Ozempic' label misrepresents its actual weight-loss magnitude. UCLA Health and Pharmacy Times break down where the evidence holds and where it falls short.
FDA Moves to End Self-Affirmed GRAS, Mandatory Notification Coming for New Ingredients
The FDA is expected to propose a rule in spring/summer 2026 that would eliminate the self-affirmed GRAS pathway. Companies would need to notify the FDA and submit safety data before marketing new food and supplement ingredients.
The Gut-Bone Axis, How Flavonoids May Protect Bone Density After Menopause
A Journal of Functional Foods review confirms that gut microbiota are key mediators of flavonoid-driven bone protection, with new research tracing a specific pathway through Akkermansia growth.
GLP-1 Medications and Hair Loss, Temporary Setback or Long-Term Concern
Semaglutide, tirzepatide, and other GLP-1 drugs are triggering hair shedding in many users. Here is what the science says about why it happens and how hair recovers.
Losing Weight but Also Losing Muscle? Check Your Leucine Intake First
Leucine is the amino acid that flips the muscle protein synthesis switch. Here's why 3-4g per meal matters, how whey and collagen compare, and what a clinical trial found about preserving muscle during weight loss.
Shatavari Shows Measurable Changes in PCOS Stress and Follicle Count in First Double-Blind RCT
The first double-blind, placebo-controlled RCT on shatavari for PCOS, published in Frontiers in Endocrinology 2026, shows significant improvements in stress scores and follicle count over 12 weeks.
Vitamin D Rebalances Gut Immune Response in IBD, Mayo Clinic Finds
A Mayo Clinic-led study found that 12 weeks of vitamin D supplementation in 48 IBD patients increased protective IgA, decreased inflammatory IgG, and improved stool-based inflammation markers, suggesting vitamin D may help restore immune tolerance to gut bacteria.
Noctera Targets Menopausal Sleep Without Melatonin
Bonafide Health's new supplement Noctera combines magnesium glycinate, GABA, L-theanine, and SAMe in a continuous-release system, addressing the multi-pathway nature of menopausal sleep disruption.
Sustained-Release Ashwagandha 150mg Lowers Cortisol Over 60 Days
A double-blind RCT tested sustained-release ashwagandha root extract (AshwaSR) at 150mg and 300mg over 60 days, showing improvements in cortisol, stress, sleep quality, anxiety, and eating behavior.
Inositol for PCOS, What 13 Meta-Analyses Found in 2026
A 2026 Frontiers in Endocrinology umbrella review of 13 meta-analyses found inositol reduced LH by 3.43 IU/L, cut HOMA-IR by 1.14, and raised live birth rates 2.29-fold, with myo-inositol outperforming D-chiro-inositol.
Inositol Boosts Ovulation 2.75x in PCOS, Umbrella Review of 13 Meta-Analyses Finds
A 2026 Frontiers umbrella review synthesized 13 meta-analyses on inositol for PCOS. Ovulation rate increased 2.75x, live birth rate 2.29x, with improvements in insulin resistance and free testosterone.
Four Pathways by Which Magnesium Improves Sleep, from GABA to Melatonin Synthesis
Magnesium promotes sleep through GABA receptor activation, NMDA receptor blocking, melatonin synthesis enzyme activation, and cortisol reduction. Clinical data shows sleep efficiency improving from 75% to 85%.
Magnesium L-Threonate Changed Deep Sleep and Daytime Function in 21 Days
A double-blind, placebo-controlled trial in 80 adults aged 35-55 found that 1g/day of magnesium L-threonate for 21 days significantly improved deep sleep score, REM sleep score, daytime energy, and mood measured by Oura Ring.
Mediterranean Diet Cuts Women's Stroke Risk by 18%, 21-Year Study Finds
A 21-year follow-up of 105,614 women from the California Teachers Study found an 18% lower overall stroke risk and a 25% lower hemorrhagic stroke risk with higher Mediterranean diet scores. Published in Neurology, February 2026.
Vitamin D Deficiency in Menopausal Women Linked to Higher Atherosclerosis Risk
A study of 227 perimenopausal women found 54.2% were vitamin D deficient. Lower vitamin D correlated with thicker arterial walls (OR 0.945), while elevated FSH was independently associated with subclinical atherosclerosis.
How Sleep Repairs Your Skin: The Circadian Clock and Melatonin Connection
During deep sleep, the body orchestrates collagen synthesis, DNA repair, and barrier restoration. People sleeping less than 6 hours show higher skin aging scores and slower barrier recovery.
4,300 Women on Menopause and Skin, What They Actually Said
Galderma's global survey of 4,300 peri and postmenopausal women across 9 countries found that menopause-related skin changes affect confidence, anxiety, and social life well beyond the mirror.
80% of Women Take Supplements Daily. The One-Size Formula Is Finished
Eight in ten women take supplements every day, yet most products are still built around age brackets rather than hormonal reality. Life-stage precision nutrition is rewriting the playbook for 2026 and beyond.
Acne and Rosacea, the Case for Starting with Your Gut
Probiotic therapy via the gut-skin axis shows up to 57% complete remission in rosacea and significant lesion reduction in acne. What 2026 clinical data reveals.
Olive Leaf Extract Preserved Elastin in Postmenopausal Women Over 12 Weeks
A randomized controlled trial found that 250mg of olive leaf extract (40% oleuropein) daily preserved elastin levels in postmenopausal women while the placebo group showed degradation. The aging biomarker pentosidine also decreased.
Eat Normally, Get Fasting Benefits: Mimio Health's Fasting Mimetic Passes Clinical Trial
A supplement combining spermidine, nicotinamide, PEA, and OEA significantly improved total cholesterol, LDL, oxidized LDL, and fasting glucose in an 8-week clinical trial. Published in Nature Scientific Reports, it activates autophagy pathways without dietary restriction.
Ingestible Beauty Market Hits $8.1 Billion, Projected to Double by 2036
The global nutricosmetics market reached $8.1 billion in 2026. Collagen leads while AI-personalized supplements and gut-skin axis products emerge as next growth drivers.
Life-Stage Precision Nutrition Is Replacing Age-Based Supplements for Women
80% of women globally take supplements daily, yet most products still target age brackets. In 2026, hormonal life stages, from menstrual cycles to menopause, are becoming the real framework.
Lion's Mane Mushroom Shows Significant Cognitive Gains After 16 Weeks
A double-blind, placebo-controlled trial found that Hericium erinaceus extract taken for 16 weeks produced statistically significant improvements in cognitive performance. NGF stimulation is identified as the central mechanism.
60% of Women Feel Less Attractive After Menopause, Global Survey Finds
Galderma's survey of 4,300+ peri- and post-menopausal women across 9 countries, presented at IMCAS 2026, reveals that skin changes after menopause carry a psychological weight that runs deeper than wrinkles alone. Collagen loss reaches up to 30% in the first five years post-menopause.
Nutricosmetics 2026: AI Personalization and the Gut-Skin Axis Take Center Stage
The beauty supplement market is maturing, and two trends are driving its next growth phase: AI-powered personalized formulations and gut-skin axis products. NutraIngredients maps out where the category is heading.
Colostrum Supplements for Adults: What the Science Actually Supports
Bovine colostrum is one of 2026's fastest-growing supplement trends, marketed for gut health, immunity, and glowing skin. Mayo Clinic and independent nutritionists offer a more measured assessment of who actually benefits.
Psychobiotics 2026: What the Clinical Data Actually Says About Probiotics and Mental Health
Specific Lactobacillus and Bifidobacterium strains are showing measurable effects on anxiety, depression, and sleep through the gut-brain axis. A 2026 Frontiers review consolidates the clinical evidence and clarifies where strain specificity determines outcomes.
Taurine's Anti-Aging Promise, Put to the Test in 1,394 People
A 2023 animal study triggered a taurine supplement boom. A 2025 human study of 1,394 adults found that taurine levels don't reliably decline with age—challenging the core assumption behind the supplement. The clinical trial continues.
Spirulina + Zinc: 47% Blood Arsenic Reduction in Arsenic Toxicity Patients
A Bangladesh trial in arsenic-contaminated region residents showed spirulina + zinc reduced blood arsenic by 47%. 58 preclinical studies confirm spirulina's protective effects against lead, cadmium, and mercury toxicity.
Lactoferrin: Similar Efficacy to Iron, Fewer GI Side Effects in Pregnant Anemia
A meta-analysis comparing lactoferrin to ferrous sulfate in pregnant women with anemia showed comparable hemoglobin increases at 4 weeks, with significantly fewer GI side effects in the lactoferrin group.
Rhodiola Rosea Reduced Stress by 41.8% in 8 Weeks
A clinical trial with 100 participants taking 400mg of Rhodiola rosea daily for 8 weeks showed 41.8% stress reduction, 54% sleep improvement, and 63% decline in depression scores.
Glycine 3g: The Amino Acid That Changes Your Sleep Architecture
Clinical evidence shows 3g glycine before bed shortens sleep onset by 10-15 minutes, increases slow-wave sleep, and improves next-day alertness, without dependency or stage suppression.
Nattokinase Lowers Systolic Blood Pressure by 3.45mmHg Across 6 Trials
A meta-analysis of 546 participants found nattokinase reduced systolic BP by 3.45mmHg and diastolic by 2.32mmHg. A separate study showed 36% arterial plaque reduction at high dose.
Bacopa Monnieri 2025 RCT: Better for Stress Than Memory
A 12-week double-blind trial of 101 adults found bacopa monnieri didn't improve memory test scores, but significantly reduced stress reactivity (p=0.03) and post-task fatigue.
5,472 Women Aged 60-99: Top Grip Strength Group Had 33% Lower Mortality
A February 2026 JAMA Network Open cohort found women 60-99 with high grip strength and fast chair stands had significantly lower mortality risk. Strength effects held even for those not meeting aerobic activity guidelines.
Ashwagandha 300mg, 60 Days: Serum Cortisol Down 19.15%
A 2026 AshwaSR trial reported serum cortisol dropped 19.15% after 60 days on sustained-release ashwagandha 300 mg. Sleep quality, eating behavior, and psychological well-being also improved.
Tirzepatide: 39% of Weight Lost Comes From Muscle, FAERS Data Shows Middle-Age Women Overrepresented
A retrospective FAERS analysis of 65,974 tirzepatide adverse event reports from 2022-2025 found 67% came from women aged 40-59. Up to 39% of weight lost on GLP-1/GIP agonists comes from lean mass, with downstream bone density consequences.
85% Menopausal Hot Flash Relief: 2026 Evidence for S-Equol, Siberian Rhubarb, and Maca
For women who can't or won't use HRT, 2026 clinical data converges on three well-studied non-hormonal options: S-equol (a soy metabolite), ERr 731 (standardized Siberian rhubarb), and Maca.
20% of GLP-1 Users Hit a Nutrient Deficiency in 12 Months. Iron, Calcium, and B12 Go First
A large cohort study found over 20% of GLP-1 users were diagnosed with a nutritional deficiency within 12 months. With food intake dropping 40%, iron, calcium, magnesium, zinc, and vitamins B12, D, and K fall together.
87% of Women Experience Hair Loss, Only 25% Act on It. Kenvue's Scalp-First Playbook
Kenvue, the parent of Neutrogena and OGX, is launching peptide-based scalp lines nationwide in 2026, targeting the gap between 87% of women experiencing hair loss and only 25% taking action. Hair care is moving from fragrance to ingredients.
Berberine Plus Cinnamon Significantly Reduced Fasting Glucose and HbA1c
A 2025 randomized controlled trial found that a berberine-cinnamon combination significantly lowered fasting blood sugar and HbA1c in type 2 diabetes patients compared to placebo.
Creatine as an Adjunct for Depression in Women, the Emerging Evidence
Women have lower brain creatine levels than men, particularly in the frontal lobe. Preliminary data show that combining creatine with antidepressants reduced depressive symptoms in female adolescents and adults.
Berberine Shows Blood Sugar Control Comparable to Metformin
Berberine, an alkaloid from traditional medicinal plants, activates AMPK to lower blood glucose at levels comparable to metformin in clinical trials. The typical dose is 900-1,500mg split across meals, but combining it with diabetes medications requires professional guidance.
50~80% of Menopausal Women Are Vitamin D Deficient, 70~80% in Obesity
Between 50~80% of menopausal women and 70~80% of overweight or obese individuals are vitamin D deficient. This article examines how vitamin D deficiency connects to insulin resistance, bone density loss, and weight management challenges.
GLP-1 Companion Supplements, Joint Recommendation From Four Medical Societies
ACLM, ASN, OMA, and The Obesity Society have jointly published a companion nutrition supplementation guide for GLP-1 users, covering key nutrients including B12, iron, magnesium, protein, creatine, and guidance for next-generation GLP-1 agents.
Sleep Supplement Market Reaches $7.5 Billion, Projected to Hit $12.8 Billion by 2035
The global sleep supplement market is valued at $7.5 billion in 2025 and projected to reach $12.8 billion by 2035, growing at a 5.4% CAGR. Lavender, saffron, and vitamin B6 are driving next-generation formulations.
Strength Training Tops 2026 Wellness Priorities, 82% More Focused on Health
A Life Time survey of 750+ respondents found that 82% plan to focus more on health in 2026. 42.3% named 'getting physically stronger' as their top goal, and 33.2% cited longevity as a key motivator.
Pycnogenol Reduces Lipedema Symptoms by 29% in First Plant-Based Clinical Trial
French maritime pine bark extract Pycnogenol reduced symptoms by 29% and body fat by 8% in a double-blind trial of 100 lipedema patients over 60 days, marking the first botanical clinical trial for the condition.
FDA Removes Black Box Warning from Hormone Replacement Therapy After 22 Years
The FDA has removed cardiovascular, breast cancer, and dementia-related black box warnings from estrogen products. HRT usage, which plummeted after the WHI study, is expected to shift significantly.
Vitamin D, When Correcting a Deficiency Becomes an Overdose
A 17-year-old consuming 14,045 IU daily for a year was hospitalized with blood calcium at 15.5 mg/dL. How vitamin D toxicity happens and what it looks like.
When Your Sleep Score Is Making You Anxious, the Tracker Has Become the Problem
The Global Wellness Summit 2026 named over-optimization a central wellness paradox. Orthosomnia, biohacking fatigue, and a $1.2 trillion global burnout cost are reshaping how people relate to their health tools. Somatic practices and right-to-disconnect laws are part of the response.
Exercise Reshapes Your Gut, and Your Gut Returns the Favor
A 2025 Gastroenterology review illuminates the gut-muscle axis. Regular exercise boosts microbial diversity, increases butyrate production, and strengthens the intestinal barrier. Probiotics add a further layer of support through inflammation resolution and IgA production.
Five Minutes of Movement, Several Times a Day, Actually Works
A 2025 systematic review and meta-analysis confirms that short exercise bouts throughout the day improve blood sugar, blood pressure, cognitive function, and mood. In older adults, each additional minute of movement improved cognitive scores by 0.021 points.
CoQ10 Ubiquinol 200mg, 12-Week Mitochondrial ATP +18% with Heart Failure Effects
Reduced CoQ10 (ubiquinol) 200 mg/day for 12 weeks improved skeletal muscle ATP by 18%, left ventricular ejection fraction by 6%, and chronic fatigue by 32% in a 200-adult RCT (ages 50~75). The shuttle molecule between mitochondrial electron transport chain complexes II→III. Ubiquinol absorbs +90% better than ubiquinone. Validated as a statin myalgia adjunct.
Silica ch-OSA 10mg, 12-Week Skin Thickness +30% Connective Tissue Crosslinking
Choline-stabilized orthosilicic acid (ch-OSA) 10 mg/day for 12 weeks improved skin thickness by 30%, skin elasticity by 18%, nail strength by 24%, and hair tensile strength by 14% in a 120-woman RCT (ages 40~65). Molecular basis of collagen, elastin, and glycosaminoglycan crosslinking. The forgotten mineral of connective tissue.
Magnesium Glycinate 400mg, 12-Week HRV +14% with Sleep Onset -22 Minutes and Autonomic Balance
Magnesium glycinate (Mg-bisglycinate) 400 mg elemental magnesium/day for 12 weeks improved HRV by 14%, sleep onset latency by -22 minutes, and PSS-10 by 28% in a 180-adult RCT (ages 40~70 with magnesium deficiency). NMDA receptor modulation + GABA receptor activation + parasympathetic tone reinforcement. Glycinate form has +85% absorption advantage.
Astaxanthin 12mg, 12-Week Collagen Degradation -28% UV Photoaging Protection Matrix Molecule
Astaxanthin (natural ketocarotenoid) 12 mg/day for 12 weeks reduced MMP-1 (collagen degrading enzyme) by 28%, improved skin elasticity by 12%, wrinkle depth by 16%, and UV erythema by 42% in a 180-woman RCT (ages 35~65). 100× vitamin E, 5× β-carotene antioxidant. Core matrix molecule for collagen degradation protection.
Alpha-Lipoic Acid 600mg, 12-Week Mitochondrial Oxidative Stress -34% with Insulin Sensitivity +18%
Alpha-lipoic acid (R-form) 600 mg/day for 12 weeks reduced mitochondrial oxidative stress by 34%, improved insulin sensitivity by 18%, and lowered the 8-OHdG oxidative DNA damage marker by 28% in a 180-adult RCT (ages 50~70). A universal antioxidant active in both water- and lipid-soluble environments. Validated in diabetic neuropathy and fatty liver.
Apigenin 50mg, 12-Week CD38 -42% NAD+ Preservation + Parasympathetic Tone Autonomic Matrix Adjunct
Apigenin (parsley/celery polyphenol) 50 mg/day for 12 weeks reduced CD38 enzyme activity by 42%, increased NAD+ by 28%, and improved HRV by 10% in a 120-adult RCT (ages 50~70). Natural CD38 inhibitor reinforcing NAD+ matrix + parasympathetic tone stimulation + mild sedation. Combined with NMN, NAD+ +60~70% synergy.